Motif 408 (n=124)
Position-wise Probabilities
Download
uniprot | genes | site | source | protein | function |
---|---|---|---|---|---|
A0A0B4J269 | None | Y687 | ochoa | Melanocyte-stimulating hormone receptor (Melanocortin receptor 1) | Receptor for MSH (alpha, beta and gamma) and ACTH. The activity of this receptor is mediated by G proteins which activate adenylate cyclase. Mediates melanogenesis, the production of eumelanin (black/brown) and phaeomelanin (red/yellow), via regulation of cAMP signaling in melanocytes. {ECO:0000256|ARBA:ARBA00023428}. |
A7E2V4 | ZSWIM8 | S559 | ochoa | Zinc finger SWIM domain-containing protein 8 | Substrate recognition component of a SCF-like E3 ubiquitin-protein ligase complex that promotes target-directed microRNA degradation (TDMD), a process that mediates degradation of microRNAs (miRNAs) (PubMed:33184234, PubMed:33184237). The SCF-like E3 ubiquitin-protein ligase complex acts by catalyzing ubiquitination and subsequent degradation of AGO proteins (AGO1, AGO2, AGO3 and/or AGO4), thereby exposing miRNAs for degradation (PubMed:33184234, PubMed:33184237). Specifically recognizes and binds AGO proteins when they are engaged with a TDMD target (PubMed:33184234). May also act as a regulator of axon guidance: specifically recognizes misfolded ROBO3 and promotes its ubiquitination and subsequent degradation (PubMed:24012004). Plays an essential role for proper embryonic development of heart and lung (By similarity). Controls protein quality of DAB1, a key signal molecule for brain development, thus protecting its signaling strength. Mechanistically, recognizes intrinsically disordered regions of DAB1 and eliminates misfolded DAB1 that cannot be properly phosphorylated (By similarity). {ECO:0000250|UniProtKB:Q3UHH1, ECO:0000269|PubMed:24012004, ECO:0000269|PubMed:33184234, ECO:0000269|PubMed:33184237}.; FUNCTION: (Microbial infection) Participates in Zika virus inhibition of IFN signaling by acting as a scaffold protein to connect ZSWIM8/CUL3 ligase complex and STAT2, leading to STAT2 degradation. {ECO:0000269|PubMed:39145933}. |
B2RUZ4 | SMIM1 | S28 | ochoa | Small integral membrane protein 1 (Vel blood group antigen) | Regulator of red blood cell formation. {ECO:0000250|UniProtKB:B3DHH5}. |
O15014 | ZNF609 | S778 | ochoa | Zinc finger protein 609 | Transcription factor, which activates RAG1, and possibly RAG2, transcription. Through the regulation of RAG1/2 expression, may regulate thymocyte maturation. Along with NIPBL and the multiprotein complex Integrator, promotes cortical neuron migration during brain development by regulating the transcription of crucial genes in this process. Preferentially binds promoters containing paused RNA polymerase II. Up-regulates the expression of SEMA3A, NRP1, PLXND1 and GABBR2 genes, among others. {ECO:0000250|UniProtKB:Q8BZ47}.; FUNCTION: [Isoform 2]: Involved in the regulation of myoblast proliferation during myogenesis. {ECO:0000269|PubMed:28344082}. |
O43166 | SIPA1L1 | S1366 | ochoa | Signal-induced proliferation-associated 1-like protein 1 (SIPA1-like protein 1) (High-risk human papilloma viruses E6 oncoproteins targeted protein 1) (E6-targeted protein 1) | Stimulates the GTPase activity of RAP2A. Promotes reorganization of the actin cytoskeleton and recruits DLG4 to F-actin. Contributes to the regulation of dendritic spine morphogenesis (By similarity). {ECO:0000250}. |
O43237 | DYNC1LI2 | S407 | ochoa | Cytoplasmic dynein 1 light intermediate chain 2 (Dynein light intermediate chain 2, cytosolic) (LIC-2) (LIC53/55) | Acts as one of several non-catalytic accessory components of the cytoplasmic dynein 1 complex that are thought to be involved in linking dynein to cargos and to adapter proteins that regulate dynein function. Cytoplasmic dynein 1 acts as a motor for the intracellular retrograde motility of vesicles and organelles along microtubules. May play a role in binding dynein to membranous organelles or chromosomes. {ECO:0000305|PubMed:36071160}. |
O60759 | CYTIP | S66 | ochoa | Cytohesin-interacting protein (Cytohesin binder and regulator) (CYBR) (Cytohesin-associated scaffolding protein) (CASP) (Cytohesin-binding protein HE) (Cbp HE) (Pleckstrin homology Sec7 and coiled-coil domains-binding protein) | By its binding to cytohesin-1 (CYTH1), it modifies activation of ARFs by CYTH1 and its precise function may be to sequester CYTH1 in the cytoplasm. |
O75122 | CLASP2 | S360 | ochoa | CLIP-associating protein 2 (Cytoplasmic linker-associated protein 2) (Protein Orbit homolog 2) (hOrbit2) | Microtubule plus-end tracking protein that promotes the stabilization of dynamic microtubules (PubMed:26003921). Involved in the nucleation of noncentrosomal microtubules originating from the trans-Golgi network (TGN). Required for the polarization of the cytoplasmic microtubule arrays in migrating cells towards the leading edge of the cell. May act at the cell cortex to enhance the frequency of rescue of depolymerizing microtubules by attaching their plus-ends to cortical platforms composed of ERC1 and PHLDB2 (PubMed:16824950). This cortical microtubule stabilizing activity is regulated at least in part by phosphatidylinositol 3-kinase signaling. Also performs a similar stabilizing function at the kinetochore which is essential for the bipolar alignment of chromosomes on the mitotic spindle (PubMed:16866869, PubMed:16914514). Acts as a mediator of ERBB2-dependent stabilization of microtubules at the cell cortex. {ECO:0000269|PubMed:11290329, ECO:0000269|PubMed:15631994, ECO:0000269|PubMed:16824950, ECO:0000269|PubMed:16866869, ECO:0000269|PubMed:16914514, ECO:0000269|PubMed:17543864, ECO:0000269|PubMed:20937854, ECO:0000269|PubMed:26003921}. |
O75179 | ANKRD17 | S1567 | ochoa | Ankyrin repeat domain-containing protein 17 (Gene trap ankyrin repeat protein) (Serologically defined breast cancer antigen NY-BR-16) | Could play pivotal roles in cell cycle and DNA regulation (PubMed:19150984). Involved in innate immune defense against viruse by positively regulating the viral dsRNA receptors DDX58 and IFIH1 signaling pathways (PubMed:22328336). Involves in NOD2- and NOD1-mediated responses to bacteria suggesting a role in innate antibacterial immune pathways too (PubMed:23711367). Target of enterovirus 71 which is the major etiological agent of HFMD (hand, foot and mouth disease) (PubMed:17276651). Could play a central role for the formation and/or maintenance of the blood vessels of the circulation system (By similarity). {ECO:0000250|UniProtKB:Q99NH0, ECO:0000269|PubMed:17276651, ECO:0000269|PubMed:19150984, ECO:0000269|PubMed:22328336, ECO:0000269|PubMed:23711367}. |
O75475 | PSIP1 | S443 | ochoa | PC4 and SFRS1-interacting protein (CLL-associated antigen KW-7) (Dense fine speckles 70 kDa protein) (DFS 70) (Lens epithelium-derived growth factor) (Transcriptional coactivator p75/p52) | Transcriptional coactivator involved in neuroepithelial stem cell differentiation and neurogenesis. Involved in particular in lens epithelial cell gene regulation and stress responses. May play an important role in lens epithelial to fiber cell terminal differentiation. May play a protective role during stress-induced apoptosis. Isoform 2 is a more general and stronger transcriptional coactivator. Isoform 2 may also act as an adapter to coordinate pre-mRNA splicing. Cellular cofactor for lentiviral integration. {ECO:0000269|PubMed:15642333}. |
O76061 | STC2 | S251 | ochoa | Stanniocalcin-2 (STC-2) (Stanniocalcin-related protein) (STC-related protein) (STCRP) | Has an anti-hypocalcemic action on calcium and phosphate homeostasis. |
O94759 | TRPM2 | S39 | psp | Transient receptor potential cation channel subfamily M member 2 (Estrogen-responsive element-associated gene 1 protein) (Long transient receptor potential channel 2) (LTrpC-2) (LTrpC2) (Transient receptor potential channel 7) (TrpC7) (Transient receptor potential melastatin 2) | [Isoform 1]: Nonselective, voltage-independent cation channel that mediates Na(+) and Ca(2+) influx, leading to increased cytoplasmic Ca(2+) levels (PubMed:11385575, PubMed:11509734, PubMed:11804595, PubMed:12594222, PubMed:15561722, PubMed:16601673, PubMed:19171771, PubMed:20660597, PubMed:25620041, PubMed:27068538, PubMed:27383051, PubMed:28775320, PubMed:29745897, PubMed:30467180, PubMed:31513012, PubMed:34788616). Functions as a ligand-gated ion channel, gated by intracellular adenosine diphosphate ribose (ADP-ribose), Ca(2+), warm temperature, and oxidative stress (PubMed:19171771, PubMed:25620041, PubMed:28775320, PubMed:30467180). The precise physiological activators are under debate; the true, physiological activators may be ADP-ribose and ADP-ribose-2'-phosphate (PubMed:20650899, PubMed:25918360). Binding of ADP-ribose to the cytoplasmic Nudix domain causes a conformation change; the channel is primed but still requires Ca(2+) binding to trigger channel opening (PubMed:19171771, PubMed:25620041, PubMed:28775320, PubMed:29745897, PubMed:30467180). Extracellular Ca(2+) passes through the channel and increases channel activity (PubMed:19171771). Contributes to Ca(2+) release from intracellular stores in response to ADP-ribose (PubMed:19454650). Plays a role in numerous processes that involve signaling via intracellular Ca(2+) levels (Probable). Besides, mediates the release of lysosomal Zn(2+) stores in response to reactive oxygen species, leading to increased cytosolic Zn(2+) levels (PubMed:25562606, PubMed:27068538). Plays a role in mediating behavorial and physiological responses to moderate heat and thereby contributes to body temperature homeostasis. Plays a role in insulin secretion, a process that requires increased cytoplasmic Ca(2+) levels (By similarity). Required for normal IFNG and cytokine secretion and normal innate immune immunity in response to bacterial infection. Required for normal phagocytosis and cytokine release by macrophages exposed to zymosan (in vitro) (PubMed:22493272). Plays a role in dendritic cell differentiation and maturation, and in dendritic cell chemotaxis via its role in regulating cytoplasmic Ca(2+) levels (By similarity). Plays a role in the regulation of the reorganization of the actin cytoskeleton and filopodia formation in response to reactive oxygen species via its role in increasing cytoplasmic Ca(2+) and Zn(2+) levels (PubMed:27068538). Confers susceptibility to cell death following oxidative stress (PubMed:12594222, PubMed:25562606). {ECO:0000250|UniProtKB:Q91YD4, ECO:0000269|PubMed:11385575, ECO:0000269|PubMed:11509734, ECO:0000269|PubMed:11804595, ECO:0000269|PubMed:11960981, ECO:0000269|PubMed:12594222, ECO:0000269|PubMed:15561722, ECO:0000269|PubMed:16601673, ECO:0000269|PubMed:19171771, ECO:0000269|PubMed:19454650, ECO:0000269|PubMed:20650899, ECO:0000269|PubMed:20660597, ECO:0000269|PubMed:22493272, ECO:0000269|PubMed:25562606, ECO:0000269|PubMed:25620041, ECO:0000269|PubMed:25918360, ECO:0000269|PubMed:27068538, ECO:0000269|PubMed:27383051, ECO:0000269|PubMed:28775320, ECO:0000269|PubMed:29745897, ECO:0000269|PubMed:30467180, ECO:0000269|PubMed:31513012, ECO:0000269|PubMed:34788616}.; FUNCTION: [Isoform 2]: Lacks cation channel activity. Does not mediate cation transport in response to oxidative stress or ADP-ribose. {ECO:0000269|PubMed:11960981}.; FUNCTION: [Isoform 3]: Lacks cation channel activity and negatively regulates the channel activity of isoform 1. Negatively regulates susceptibility to cell death in reposponse to oxidative stress. {ECO:0000269|PubMed:12594222}. |
O94888 | UBXN7 | S270 | ochoa | UBX domain-containing protein 7 | Ubiquitin-binding adapter that links a subset of NEDD8-associated cullin ring ligases (CRLs) to the segregase VCP/p97, to regulate turnover of their ubiquitination substrates. {ECO:0000269|PubMed:22537386}. |
P04350 | TUBB4A | Y340 | ochoa | Tubulin beta-4A chain (Tubulin 5 beta) (Tubulin beta-4 chain) | Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers. Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin. |
P05165 | PCCA | S252 | ochoa | Propionyl-CoA carboxylase alpha chain, mitochondrial (PCCase subunit alpha) (EC 6.4.1.3) (Propanoyl-CoA:carbon dioxide ligase subunit alpha) | This is one of the 2 subunits of the biotin-dependent propionyl-CoA carboxylase (PCC), a mitochondrial enzyme involved in the catabolism of odd chain fatty acids, branched-chain amino acids isoleucine, threonine, methionine, and valine and other metabolites (PubMed:6765947, PubMed:8434582). Propionyl-CoA carboxylase catalyzes the carboxylation of propionyl-CoA/propanoyl-CoA to D-methylmalonyl-CoA/(S)-methylmalonyl-CoA (PubMed:10101253, PubMed:6765947, PubMed:8434582). Within the holoenzyme, the alpha subunit catalyzes the ATP-dependent carboxylation of the biotin carried by the biotin carboxyl carrier (BCC) domain, while the beta subunit then transfers the carboxyl group from carboxylated biotin to propionyl-CoA (By similarity). Propionyl-CoA carboxylase also significantly acts on butyryl-CoA/butanoyl-CoA, which is converted to ethylmalonyl-CoA/(2S)-ethylmalonyl-CoA at a much lower rate (PubMed:6765947). Other alternative minor substrates include (2E)-butenoyl-CoA/crotonoyl-CoA (By similarity). {ECO:0000250|UniProtKB:P0DTA4, ECO:0000250|UniProtKB:Q5LUF3, ECO:0000269|PubMed:10101253, ECO:0000269|PubMed:6765947, ECO:0000269|PubMed:8434582}. |
P05549 | TFAP2A | T224 | ochoa | Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2) | Sequence-specific DNA-binding protein that interacts with inducible viral and cellular enhancer elements to regulate transcription of selected genes. AP-2 factors bind to the consensus sequence 5'-GCCNNNGGC-3' and activate genes involved in a large spectrum of important biological functions including proper eye, face, body wall, limb and neural tube development. They also suppress a number of genes including MCAM/MUC18, C/EBP alpha and MYC. AP-2-alpha is the only AP-2 protein required for early morphogenesis of the lens vesicle. Together with the CITED2 coactivator, stimulates the PITX2 P1 promoter transcription activation. Associates with chromatin to the PITX2 P1 promoter region. {ECO:0000269|PubMed:11694877, ECO:0000269|PubMed:12586840}. |
P07437 | TUBB | Y340 | ochoa | Tubulin beta chain (Tubulin beta-5 chain) | Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers. Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin. |
P11055 | MYH3 | S644 | ochoa | Myosin-3 (Muscle embryonic myosin heavy chain) (Myosin heavy chain 3) (Myosin heavy chain, fast skeletal muscle, embryonic) (SMHCE) | Muscle contraction. |
P12268 | IMPDH2 | S426 | ochoa | Inosine-5'-monophosphate dehydrogenase 2 (IMP dehydrogenase 2) (IMPD 2) (IMPDH 2) (EC 1.1.1.205) (Inosine-5'-monophosphate dehydrogenase type II) (IMP dehydrogenase II) (IMPDH-II) | Catalyzes the conversion of inosine 5'-phosphate (IMP) to xanthosine 5'-phosphate (XMP), the first committed and rate-limiting step in the de novo synthesis of guanine nucleotides, and therefore plays an important role in the regulation of cell growth (PubMed:7763314, PubMed:7903306). Could also have a single-stranded nucleic acid-binding activity and could play a role in RNA and/or DNA metabolism (PubMed:14766016). It may also have a role in the development of malignancy and the growth progression of some tumors. {ECO:0000269|PubMed:14766016, ECO:0000269|PubMed:7763314, ECO:0000269|PubMed:7903306}. |
P12882 | MYH1 | S647 | ochoa | Myosin-1 (Myosin heavy chain 1) (Myosin heavy chain 2x) (MyHC-2x) (Myosin heavy chain IIx/d) (MyHC-IIx/d) (Myosin heavy chain, skeletal muscle, adult 1) | Required for normal hearing. It plays a role in cochlear amplification of auditory stimuli, likely through the positive regulation of prestin (SLC26A5) activity and outer hair cell (OHC) electromotility. {ECO:0000250|UniProtKB:Q5SX40}. |
P12883 | MYH7 | S643 | ochoa | Myosin-7 (Myosin heavy chain 7) (Myosin heavy chain slow isoform) (MyHC-slow) (Myosin heavy chain, cardiac muscle beta isoform) (MyHC-beta) | Myosins are actin-based motor molecules with ATPase activity essential for muscle contraction. Forms regular bipolar thick filaments that, together with actin thin filaments, constitute the fundamental contractile unit of skeletal and cardiac muscle. {ECO:0000305|PubMed:26150528, ECO:0000305|PubMed:26246073}. |
P13533 | MYH6 | S645 | ochoa | Myosin-6 (Myosin heavy chain 6) (Myosin heavy chain, cardiac muscle alpha isoform) (MyHC-alpha) | Muscle contraction. |
P13535 | MYH8 | S646 | ochoa | Myosin-8 (Myosin heavy chain 8) (Myosin heavy chain, skeletal muscle, perinatal) (MyHC-perinatal) | Muscle contraction. |
P17661 | DES | S47 | ochoa | Desmin | Muscle-specific type III intermediate filament essential for proper muscular structure and function. Plays a crucial role in maintaining the structure of sarcomeres, inter-connecting the Z-disks and forming the myofibrils, linking them not only to the sarcolemmal cytoskeleton, but also to the nucleus and mitochondria, thus providing strength for the muscle fiber during activity (PubMed:25358400). In adult striated muscle they form a fibrous network connecting myofibrils to each other and to the plasma membrane from the periphery of the Z-line structures (PubMed:24200904, PubMed:25394388, PubMed:26724190). May act as a sarcomeric microtubule-anchoring protein: specifically associates with detyrosinated tubulin-alpha chains, leading to buckled microtubules and mechanical resistance to contraction. Required for nuclear membrane integrity, via anchoring at the cell tip and nuclear envelope, resulting in maintenance of microtubule-derived intracellular mechanical forces (By similarity). Contributes to the transcriptional regulation of the NKX2-5 gene in cardiac progenitor cells during a short period of cardiomyogenesis and in cardiac side population stem cells in the adult. Plays a role in maintaining an optimal conformation of nebulette (NEB) on heart muscle sarcomeres to bind and recruit cardiac alpha-actin (By similarity). {ECO:0000250|UniProtKB:P31001, ECO:0000269|PubMed:24200904, ECO:0000269|PubMed:25394388, ECO:0000269|PubMed:26724190, ECO:0000303|PubMed:25358400}. |
P28715 | ERCC5 | S1069 | ochoa | DNA excision repair protein ERCC-5 (EC 3.1.-.-) (DNA repair protein complementing XP-G cells) (XPG) (Xeroderma pigmentosum group G-complementing protein) | Single-stranded structure-specific DNA endonuclease involved in DNA excision repair (PubMed:32522879, PubMed:32821917, PubMed:7651464, PubMed:8078765, PubMed:8090225, PubMed:8206890). Makes the 3'incision in DNA nucleotide excision repair (NER) (PubMed:32522879, PubMed:32821917, PubMed:8078765, PubMed:8090225). Binds and bends DNA repair bubble substrate and breaks base stacking at the single-strand/double-strand DNA junction of the DNA bubble (PubMed:32522879). Plays a role in base excision repair (BER) by promoting the binding of DNA glycosylase NTHL1 to its substrate and increasing NTHL1 catalytic activity that removes oxidized pyrimidines from DNA (PubMed:9927729). Involved in transcription-coupled nucleotide excision repair (TCR) which allows RNA polymerase II-blocking lesions to be rapidly removed from the transcribed strand of active genes (PubMed:16246722). Functions during the initial step of TCR in cooperation with ERCC6/CSB to recognized stalled RNA polymerase II (PubMed:16246722). Also, stimulates ERCC6/CSB binding to the DNA repair bubble and ERCC6/CSB ATPase activity (PubMed:16246722). Required for DNA replication fork maintenance and preservation of genomic stability (PubMed:26833090, PubMed:32522879). Involved in homologous recombination repair (HRR) induced by DNA replication stress by recruiting RAD51, BRCA2, and PALB2 to the damaged DNA site (PubMed:26833090). In TFIIH stimulates the 5'-3' helicase activity of XPD/ERCC2 and the DNA translocase activity of XPB/ERCC3 (PubMed:31253769). During HRR, binds to the replication fork with high specificity and stabilizes it (PubMed:32522879). Also, acts upstream of HRR, to promote the release of BRCA1 from DNA (PubMed:26833090). {ECO:0000269|PubMed:16246722, ECO:0000269|PubMed:26833090, ECO:0000269|PubMed:31253769, ECO:0000269|PubMed:32522879, ECO:0000269|PubMed:32821917, ECO:0000269|PubMed:7651464, ECO:0000269|PubMed:8078765, ECO:0000269|PubMed:8090225, ECO:0000269|PubMed:8206890, ECO:0000269|PubMed:9927729}. |
P42566 | EPS15 | S607 | ochoa | Epidermal growth factor receptor substrate 15 (Protein Eps15) (Protein AF-1p) | Involved in cell growth regulation. May be involved in the regulation of mitogenic signals and control of cell proliferation. Involved in the internalization of ligand-inducible receptors of the receptor tyrosine kinase (RTK) type, in particular EGFR. Plays a role in the assembly of clathrin-coated pits (CCPs). Acts as a clathrin adapter required for post-Golgi trafficking. Seems to be involved in CCPs maturation including invagination or budding. Involved in endocytosis of integrin beta-1 (ITGB1) and transferrin receptor (TFR); internalization of ITGB1 as DAB2-dependent cargo but not TFR seems to require association with DAB2. {ECO:0000269|PubMed:16903783, ECO:0000269|PubMed:18362181, ECO:0000269|PubMed:19458185, ECO:0000269|PubMed:22648170}. |
P49790 | NUP153 | S938 | ochoa | Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153) | Component of the nuclear pore complex (NPC), a complex required for the trafficking across the nuclear envelope. Functions as a scaffolding element in the nuclear phase of the NPC essential for normal nucleocytoplasmic transport of proteins and mRNAs. Involved in the quality control and retention of unspliced mRNAs in the nucleus; in association with TPR, regulates the nuclear export of unspliced mRNA species bearing constitutive transport element (CTE) in a NXF1- and KHDRBS1-independent manner. Mediates TPR anchoring to the nuclear membrane at NPC. The repeat-containing domain may be involved in anchoring other components of the NPC to the pore membrane. Possible DNA-binding subunit of the nuclear pore complex (NPC). {ECO:0000269|PubMed:12802065, ECO:0000269|PubMed:15229283, ECO:0000269|PubMed:22253824}.; FUNCTION: (Microbial infection) Interacts with HIV-1 caspid protein P24 and thereby promotes the integration of the virus in the nucleus of non-dividing cells (in vitro). {ECO:0000269|PubMed:23523133, ECO:0000269|PubMed:24130490, ECO:0000269|PubMed:29997211}.; FUNCTION: (Microbial infection) Binds HIV-2 protein vpx and thereby promotes the nuclear translocation of the lentiviral genome (in vitro). {ECO:0000269|PubMed:24130490, ECO:0000269|PubMed:31913756}. |
P49916 | LIG3 | S854 | ochoa | DNA ligase 3 (EC 6.5.1.1) (DNA ligase III) (Polydeoxyribonucleotide synthase [ATP] 3) | Isoform 3 functions as a heterodimer with DNA-repair protein XRCC1 in the nucleus and can correct defective DNA strand-break repair and sister chromatid exchange following treatment with ionizing radiation and alkylating agents. Isoform 1 is targeted to mitochondria, where it functions as a DNA ligase in mitochondrial base-excision DNA repair (PubMed:10207110, PubMed:24674627). {ECO:0000269|PubMed:10207110, ECO:0000269|PubMed:24674627}. |
P54259 | ATN1 | S42 | ochoa | Atrophin-1 (Dentatorubral-pallidoluysian atrophy protein) | Transcriptional corepressor. Recruits NR2E1 to repress transcription. Promotes vascular smooth cell (VSMC) migration and orientation (By similarity). Corepressor of MTG8 transcriptional repression. Has some intrinsic repression activity which is independent of the number of poly-Gln (polyQ) repeats. {ECO:0000250|UniProtKB:O35126, ECO:0000269|PubMed:10085113, ECO:0000269|PubMed:10973986}. |
P54296 | MYOM2 | S1274 | ochoa | Myomesin-2 (165 kDa connectin-associated protein) (165 kDa titin-associated protein) (M-protein) (Myomesin family member 2) | Major component of the vertebrate myofibrillar M band. Binds myosin, titin, and light meromyosin. This binding is dose dependent. |
P55201 | BRPF1 | S867 | ochoa | Peregrin (Bromodomain and PHD finger-containing protein 1) (Protein Br140) | Scaffold subunit of various histone acetyltransferase (HAT) complexes, such as the MOZ/MORF and HBO1 complexes, which have a histone H3 acetyltransferase activity (PubMed:16387653, PubMed:24065767, PubMed:27939640). Plays a key role in HBO1 complex by directing KAT7/HBO1 specificity towards histone H3 'Lys-14' acetylation (H3K14ac) (PubMed:24065767). Some HAT complexes preferentially mediate histone H3 'Lys-23' (H3K23ac) acetylation (PubMed:27939640). Positively regulates the transcription of RUNX1 and RUNX2 (PubMed:18794358). {ECO:0000269|PubMed:16387653, ECO:0000269|PubMed:18794358, ECO:0000269|PubMed:24065767, ECO:0000269|PubMed:27939640}. |
P63241 | EIF5A | S46 | ochoa | Eukaryotic translation initiation factor 5A-1 (eIF-5A-1) (eIF-5A1) (Eukaryotic initiation factor 5A isoform 1) (eIF-5A) (Rev-binding factor) (eIF-4D) | Translation factor that promotes translation elongation and termination, particularly upon ribosome stalling at specific amino acid sequence contexts (PubMed:33547280). Binds between the exit (E) and peptidyl (P) site of the ribosome and promotes rescue of stalled ribosome: specifically required for efficient translation of polyproline-containing peptides as well as other motifs that stall the ribosome (By similarity). Acts as a ribosome quality control (RQC) cofactor by joining the RQC complex to facilitate peptidyl transfer during CAT tailing step (By similarity). Also involved in actin dynamics and cell cycle progression, mRNA decay and probably in a pathway involved in stress response and maintenance of cell wall integrity (PubMed:16987817). With syntenin SDCBP, functions as a regulator of p53/TP53 and p53/TP53-dependent apoptosis (PubMed:15371445). Also regulates TNF-alpha-mediated apoptosis (PubMed:15452064, PubMed:17187778). Mediates effects of polyamines on neuronal process extension and survival (PubMed:17360499). Is required for autophagy by assisting the ribosome in translating the ATG3 protein at a specific amino acid sequence, the 'ASP-ASP-Gly' motif, leading to the increase of the efficiency of ATG3 translation and facilitation of LC3B lipidation and autophagosome formation (PubMed:29712776). {ECO:0000250|UniProtKB:P23301, ECO:0000269|PubMed:15371445, ECO:0000269|PubMed:15452064, ECO:0000269|PubMed:16987817, ECO:0000269|PubMed:17187778, ECO:0000269|PubMed:17360499, ECO:0000269|PubMed:29712776, ECO:0000269|PubMed:33547280}.; FUNCTION: (Microbial infection) Cellular cofactor of human T-cell leukemia virus type I (HTLV-1) Rex protein and of human immunodeficiency virus type 1 (HIV-1) Rev protein, essential for mRNA export of retroviral transcripts. {ECO:0000269|PubMed:8253832}. |
P68371 | TUBB4B | Y340 | ochoa | Tubulin beta-4B chain (Tubulin beta-2 chain) (Tubulin beta-2C chain) | Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers. Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin. |
P98171 | ARHGAP4 | S217 | ochoa | Rho GTPase-activating protein 4 (Rho-GAP hematopoietic protein C1) (Rho-type GTPase-activating protein 4) (p115) | Inhibitory effect on stress fiber organization. May down-regulate Rho-like GTPase in hematopoietic cells. |
Q01831 | XPC | S399 | ochoa | DNA repair protein complementing XP-C cells (Xeroderma pigmentosum group C-complementing protein) (p125) | Involved in global genome nucleotide excision repair (GG-NER) by acting as damage sensing and DNA-binding factor component of the XPC complex (PubMed:10734143, PubMed:10873465, PubMed:12509299, PubMed:12547395, PubMed:19609301, PubMed:19941824, PubMed:20028083, PubMed:20649465, PubMed:20798892, PubMed:9734359). Has only a low DNA repair activity by itself which is stimulated by RAD23B and RAD23A. Has a preference to bind DNA containing a short single-stranded segment but not to damaged oligonucleotides (PubMed:10734143, PubMed:19609301, PubMed:20649465). This feature is proposed to be related to a dynamic sensor function: XPC can rapidly screen duplex DNA for non-hydrogen-bonded bases by forming a transient nucleoprotein intermediate complex which matures into a stable recognition complex through an intrinsic single-stranded DNA-binding activity (PubMed:10734143, PubMed:19609301, PubMed:20649465). The XPC complex is proposed to represent the first factor bound at the sites of DNA damage and together with other core recognition factors, XPA, RPA and the TFIIH complex, is part of the pre-incision (or initial recognition) complex (PubMed:10873465, PubMed:12509299, PubMed:12547395, PubMed:19941824, PubMed:20028083, PubMed:20798892, PubMed:9734359). The XPC complex recognizes a wide spectrum of damaged DNA characterized by distortions of the DNA helix such as single-stranded loops, mismatched bubbles or single-stranded overhangs (PubMed:10873465, PubMed:12509299, PubMed:12547395, PubMed:19941824, PubMed:20028083, PubMed:20798892, PubMed:9734359). The orientation of XPC complex binding appears to be crucial for inducing a productive NER (PubMed:10873465, PubMed:12509299, PubMed:12547395, PubMed:19941824, PubMed:20028083, PubMed:20798892, PubMed:9734359). XPC complex is proposed to recognize and to interact with unpaired bases on the undamaged DNA strand which is followed by recruitment of the TFIIH complex and subsequent scanning for lesions in the opposite strand in a 5'-to-3' direction by the NER machinery (PubMed:10873465, PubMed:12509299, PubMed:12547395, PubMed:19941824, PubMed:20028083, PubMed:20798892, PubMed:9734359). Cyclobutane pyrimidine dimers (CPDs) which are formed upon UV-induced DNA damage esacpe detection by the XPC complex due to a low degree of structural perurbation. Instead they are detected by the UV-DDB complex which in turn recruits and cooperates with the XPC complex in the respective DNA repair (PubMed:10873465, PubMed:12509299, PubMed:12547395, PubMed:19941824, PubMed:20028083, PubMed:20798892, PubMed:9734359). In vitro, the XPC:RAD23B dimer is sufficient to initiate NER; it preferentially binds to cisplatin and UV-damaged double-stranded DNA and also binds to a variety of chemically and structurally diverse DNA adducts (PubMed:20028083). XPC:RAD23B contacts DNA both 5' and 3' of a cisplatin lesion with a preference for the 5' side. XPC:RAD23B induces a bend in DNA upon binding. XPC:RAD23B stimulates the activity of DNA glycosylases TDG and SMUG1 (PubMed:20028083). {ECO:0000269|PubMed:10734143, ECO:0000269|PubMed:10873465, ECO:0000269|PubMed:12509299, ECO:0000269|PubMed:12547395, ECO:0000269|PubMed:19609301, ECO:0000269|PubMed:19941824, ECO:0000269|PubMed:20028083, ECO:0000269|PubMed:20649465, ECO:0000269|PubMed:20798892, ECO:0000269|PubMed:9734359}.; FUNCTION: In absence of DNA repair, the XPC complex also acts as a transcription coactivator: XPC interacts with the DNA-binding transcription factor E2F1 at a subset of promoters to recruit KAT2A and histone acetyltransferase complexes (HAT) (PubMed:29973595, PubMed:31527837). KAT2A recruitment specifically promotes acetylation of histone variant H2A.Z.1/H2A.Z, but not H2A.Z.2/H2A.V, thereby promoting expression of target genes (PubMed:31527837). {ECO:0000269|PubMed:29973595, ECO:0000269|PubMed:31527837}. |
Q08945 | SSRP1 | S673 | ochoa | FACT complex subunit SSRP1 (Chromatin-specific transcription elongation factor 80 kDa subunit) (Facilitates chromatin transcription complex 80 kDa subunit) (FACT 80 kDa subunit) (FACTp80) (Facilitates chromatin transcription complex subunit SSRP1) (Recombination signal sequence recognition protein 1) (Structure-specific recognition protein 1) (hSSRP1) (T160) | Component of the FACT complex, a general chromatin factor that acts to reorganize nucleosomes. The FACT complex is involved in multiple processes that require DNA as a template such as mRNA elongation, DNA replication and DNA repair. During transcription elongation the FACT complex acts as a histone chaperone that both destabilizes and restores nucleosomal structure. It facilitates the passage of RNA polymerase II and transcription by promoting the dissociation of one histone H2A-H2B dimer from the nucleosome, then subsequently promotes the reestablishment of the nucleosome following the passage of RNA polymerase II. The FACT complex is probably also involved in phosphorylation of 'Ser-392' of p53/TP53 via its association with CK2 (casein kinase II). Binds specifically to double-stranded DNA and at low levels to DNA modified by the antitumor agent cisplatin. May potentiate cisplatin-induced cell death by blocking replication and repair of modified DNA. Also acts as a transcriptional coactivator for p63/TP63. {ECO:0000269|PubMed:10912001, ECO:0000269|PubMed:11239457, ECO:0000269|PubMed:12374749, ECO:0000269|PubMed:12934006, ECO:0000269|PubMed:16713563, ECO:0000269|PubMed:9489704, ECO:0000269|PubMed:9566881, ECO:0000269|PubMed:9836642}. |
Q09666 | AHNAK | S177 | ochoa | Neuroblast differentiation-associated protein AHNAK (Desmoyokin) | May be required for neuronal cell differentiation. |
Q09666 | AHNAK | S282 | ochoa | Neuroblast differentiation-associated protein AHNAK (Desmoyokin) | May be required for neuronal cell differentiation. |
Q12802 | AKAP13 | S1619 | ochoa | A-kinase anchor protein 13 (AKAP-13) (AKAP-Lbc) (Breast cancer nuclear receptor-binding auxiliary protein) (Guanine nucleotide exchange factor Lbc) (Human thyroid-anchoring protein 31) (Lymphoid blast crisis oncogene) (LBC oncogene) (Non-oncogenic Rho GTPase-specific GTP exchange factor) (Protein kinase A-anchoring protein 13) (PRKA13) (p47) | Scaffold protein that plays an important role in assembling signaling complexes downstream of several types of G protein-coupled receptors. Activates RHOA in response to signaling via G protein-coupled receptors via its function as Rho guanine nucleotide exchange factor (PubMed:11546812, PubMed:15229649, PubMed:23090968, PubMed:24993829, PubMed:25186459). May also activate other Rho family members (PubMed:11546812). Part of a kinase signaling complex that links ADRA1A and ADRA1B adrenergic receptor signaling to the activation of downstream p38 MAP kinases, such as MAPK11 and MAPK14 (PubMed:17537920, PubMed:21224381, PubMed:23716597). Part of a signaling complex that links ADRA1B signaling to the activation of RHOA and IKBKB/IKKB, leading to increased NF-kappa-B transcriptional activity (PubMed:23090968). Part of a RHOA-dependent signaling cascade that mediates responses to lysophosphatidic acid (LPA), a signaling molecule that activates G-protein coupled receptors and potentiates transcriptional activation of the glucocorticoid receptor NR3C1 (PubMed:16469733). Part of a signaling cascade that stimulates MEF2C-dependent gene expression in response to lysophosphatidic acid (LPA) (By similarity). Part of a signaling pathway that activates MAPK11 and/or MAPK14 and leads to increased transcription activation of the estrogen receptors ESR1 and ESR2 (PubMed:11579095, PubMed:9627117). Part of a signaling cascade that links cAMP and EGFR signaling to BRAF signaling and to PKA-mediated phosphorylation of KSR1, leading to the activation of downstream MAP kinases, such as MAPK1 or MAPK3 (PubMed:21102438). Functions as a scaffold protein that anchors cAMP-dependent protein kinase (PKA) and PRKD1. This promotes activation of PRKD1, leading to increased phosphorylation of HDAC5 and ultimately cardiomyocyte hypertrophy (By similarity). Has no guanine nucleotide exchange activity on CDC42, Ras or Rac (PubMed:11546812). Required for normal embryonic heart development, and in particular for normal sarcomere formation in the developing cardiomyocytes (By similarity). Plays a role in cardiomyocyte growth and cardiac hypertrophy in response to activation of the beta-adrenergic receptor by phenylephrine or isoproterenol (PubMed:17537920, PubMed:23090968). Required for normal adaptive cardiac hypertrophy in response to pressure overload (PubMed:23716597). Plays a role in osteogenesis (By similarity). {ECO:0000250|UniProtKB:E9Q394, ECO:0000269|PubMed:11546812, ECO:0000269|PubMed:11579095, ECO:0000269|PubMed:17537920, ECO:0000269|PubMed:21224381, ECO:0000269|PubMed:23716597, ECO:0000269|PubMed:24993829, ECO:0000269|PubMed:25186459, ECO:0000269|PubMed:9627117, ECO:0000269|PubMed:9891067}. |
Q12888 | TP53BP1 | S1311 | ochoa | TP53-binding protein 1 (53BP1) (p53-binding protein 1) (p53BP1) | Double-strand break (DSB) repair protein involved in response to DNA damage, telomere dynamics and class-switch recombination (CSR) during antibody genesis (PubMed:12364621, PubMed:17190600, PubMed:21144835, PubMed:22553214, PubMed:23333306, PubMed:27153538, PubMed:28241136, PubMed:31135337, PubMed:37696958). Plays a key role in the repair of double-strand DNA breaks (DSBs) in response to DNA damage by promoting non-homologous end joining (NHEJ)-mediated repair of DSBs and specifically counteracting the function of the homologous recombination (HR) repair protein BRCA1 (PubMed:22553214, PubMed:23333306, PubMed:23727112, PubMed:27153538, PubMed:31135337). In response to DSBs, phosphorylation by ATM promotes interaction with RIF1 and dissociation from NUDT16L1/TIRR, leading to recruitment to DSBs sites (PubMed:28241136). Recruited to DSBs sites by recognizing and binding histone H2A monoubiquitinated at 'Lys-15' (H2AK15Ub) and histone H4 dimethylated at 'Lys-20' (H4K20me2), two histone marks that are present at DSBs sites (PubMed:17190600, PubMed:23760478, PubMed:27153538, PubMed:28241136). Required for immunoglobulin class-switch recombination (CSR) during antibody genesis, a process that involves the generation of DNA DSBs (PubMed:23345425). Participates in the repair and the orientation of the broken DNA ends during CSR (By similarity). In contrast, it is not required for classic NHEJ and V(D)J recombination (By similarity). Promotes NHEJ of dysfunctional telomeres via interaction with PAXIP1 (PubMed:23727112). {ECO:0000250|UniProtKB:P70399, ECO:0000269|PubMed:12364621, ECO:0000269|PubMed:17190600, ECO:0000269|PubMed:21144835, ECO:0000269|PubMed:22553214, ECO:0000269|PubMed:23333306, ECO:0000269|PubMed:23345425, ECO:0000269|PubMed:23727112, ECO:0000269|PubMed:23760478, ECO:0000269|PubMed:27153538, ECO:0000269|PubMed:28241136, ECO:0000269|PubMed:31135337, ECO:0000269|PubMed:37696958}. |
Q13422 | IKZF1 | S215 | psp | DNA-binding protein Ikaros (Ikaros family zinc finger protein 1) (Lymphoid transcription factor LyF-1) | Transcription regulator of hematopoietic cell differentiation (PubMed:17934067). Binds gamma-satellite DNA (PubMed:17135265, PubMed:19141594). Plays a role in the development of lymphocytes, B- and T-cells. Binds and activates the enhancer (delta-A element) of the CD3-delta gene. Repressor of the TDT (fikzfterminal deoxynucleotidyltransferase) gene during thymocyte differentiation. Regulates transcription through association with both HDAC-dependent and HDAC-independent complexes. Targets the 2 chromatin-remodeling complexes, NuRD and BAF (SWI/SNF), in a single complex (PYR complex), to the beta-globin locus in adult erythrocytes. Increases normal apoptosis in adult erythroid cells. Confers early temporal competence to retinal progenitor cells (RPCs) (By similarity). Function is isoform-specific and is modulated by dominant-negative inactive isoforms (PubMed:17135265, PubMed:17934067). {ECO:0000250|UniProtKB:Q03267, ECO:0000269|PubMed:10204490, ECO:0000269|PubMed:17135265, ECO:0000269|PubMed:17934067, ECO:0000269|PubMed:19141594}. |
Q13509 | TUBB3 | Y340 | ochoa|psp | Tubulin beta-3 chain (Tubulin beta-4 chain) (Tubulin beta-III) | Tubulin is the major constituent of microtubules, protein filaments consisting of alpha- and beta-tubulin heterodimers (PubMed:34996871, PubMed:38305685, PubMed:38609661). Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms (PubMed:34996871, PubMed:38305685, PubMed:38609661). Below the cap, alpha-beta tubulin heterodimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin (PubMed:34996871, PubMed:38609661). TUBB3 plays a critical role in proper axon guidance and maintenance (PubMed:20074521). Binding of NTN1/Netrin-1 to its receptor UNC5C might cause dissociation of UNC5C from polymerized TUBB3 in microtubules and thereby lead to increased microtubule dynamics and axon repulsion (PubMed:28483977). Plays a role in dorsal root ganglion axon projection towards the spinal cord (PubMed:28483977). {ECO:0000269|PubMed:20074521, ECO:0000269|PubMed:28483977, ECO:0000269|PubMed:34996871, ECO:0000269|PubMed:38305685, ECO:0000269|PubMed:38609661}. |
Q13561 | DCTN2 | S203 | ochoa | Dynactin subunit 2 (50 kDa dynein-associated polypeptide) (Dynactin complex 50 kDa subunit) (DCTN-50) (p50 dynamitin) | Part of the dynactin complex that activates the molecular motor dynein for ultra-processive transport along microtubules. In the dynactin soulder domain, binds the ACTR1A filament and acts as a molecular ruler to determine the length (By similarity). Modulates cytoplasmic dynein binding to an organelle, and plays a role in prometaphase chromosome alignment and spindle organization during mitosis. Involved in anchoring microtubules to centrosomes. May play a role in synapse formation during brain development (By similarity). {ECO:0000250|UniProtKB:A0A5G2QD80, ECO:0000250|UniProtKB:Q99KJ8}. |
Q13625 | TP53BP2 | S683 | ochoa | Apoptosis-stimulating of p53 protein 2 (Bcl2-binding protein) (Bbp) (Renal carcinoma antigen NY-REN-51) (Tumor suppressor p53-binding protein 2) (53BP2) (p53-binding protein 2) (p53BP2) | Regulator that plays a central role in regulation of apoptosis and cell growth via its interactions with proteins such as TP53 (PubMed:12524540). Regulates TP53 by enhancing the DNA binding and transactivation function of TP53 on the promoters of proapoptotic genes in vivo. Inhibits the ability of NAE1 to conjugate NEDD8 to CUL1, and thereby decreases NAE1 ability to induce apoptosis. Impedes cell cycle progression at G2/M. Its apoptosis-stimulating activity is inhibited by its interaction with DDX42. {ECO:0000269|PubMed:11684014, ECO:0000269|PubMed:12524540, ECO:0000269|PubMed:12694406, ECO:0000269|PubMed:19377511}. |
Q13772 | NCOA4 | S554 | ochoa | Nuclear receptor coactivator 4 (NCoA-4) (Androgen receptor coactivator 70 kDa protein) (70 kDa AR-activator) (70 kDa androgen receptor coactivator) (Androgen receptor-associated protein of 70 kDa) (Ferritin cargo receptor NCOA4) (Ret-activating protein ELE1) | Cargo receptor for the autophagic turnover of the iron-binding ferritin complex, playing a central role in iron homeostasis (PubMed:25327288, PubMed:26436293). Acts as an adapter for delivery of ferritin to lysosomes and autophagic degradation of ferritin, a process named ferritinophagy (PubMed:25327288, PubMed:26436293). Targets the iron-binding ferritin complex to autolysosomes following starvation or iron depletion (PubMed:25327288). Ensures efficient erythropoiesis, possibly by regulating hemin-induced erythroid differentiation (PubMed:26436293). In some studies, has been shown to enhance the androgen receptor AR transcriptional activity as well as acting as ligand-independent coactivator of the peroxisome proliferator-activated receptor (PPAR) gamma (PubMed:10347167, PubMed:8643607). Another study shows only weak behavior as a coactivator for the androgen receptor and no alteration of the ligand responsiveness of the AR (PubMed:10517667). Binds to DNA replication origins, binding is not restricted to sites of active transcription and may likely be independent from the nuclear receptor transcriptional coactivator function (PubMed:24910095). May inhibit activation of DNA replication origins, possibly by obstructing DNA unwinding via interaction with the MCM2-7 complex (PubMed:24910095). {ECO:0000269|PubMed:10347167, ECO:0000269|PubMed:10517667, ECO:0000269|PubMed:24910095, ECO:0000269|PubMed:25327288, ECO:0000269|PubMed:26436293, ECO:0000269|PubMed:8643607}. |
Q13885 | TUBB2A | Y340 | ochoa | Tubulin beta-2A chain (Tubulin beta class IIa) | Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers. Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin. |
Q14151 | SAFB2 | S195 | ochoa | Scaffold attachment factor B2 (SAF-B2) | Binds to scaffold/matrix attachment region (S/MAR) DNA. Can function as an estrogen receptor corepressor and can also inhibit cell proliferation. |
Q14247 | CTTN | S282 | ochoa | Src substrate cortactin (Amplaxin) (Oncogene EMS1) | Contributes to the organization of the actin cytoskeleton and cell shape (PubMed:21296879). Plays a role in the formation of lamellipodia and in cell migration. Plays a role in the regulation of neuron morphology, axon growth and formation of neuronal growth cones (By similarity). Through its interaction with CTTNBP2, involved in the regulation of neuronal spine density (By similarity). Plays a role in focal adhesion assembly and turnover (By similarity). In complex with ABL1 and MYLK regulates cortical actin-based cytoskeletal rearrangement critical to sphingosine 1-phosphate (S1P)-mediated endothelial cell (EC) barrier enhancement (PubMed:20861316). Plays a role in intracellular protein transport and endocytosis, and in modulating the levels of potassium channels present at the cell membrane (PubMed:17959782). Plays a role in receptor-mediated endocytosis via clathrin-coated pits (By similarity). Required for stabilization of KCNH1 channels at the cell membrane (PubMed:23144454). Plays a role in the invasiveness of cancer cells, and the formation of metastases (PubMed:16636290). {ECO:0000250|UniProtKB:Q60598, ECO:0000250|UniProtKB:Q66HL2, ECO:0000269|PubMed:16636290, ECO:0000269|PubMed:17959782, ECO:0000269|PubMed:21296879, ECO:0000269|PubMed:23144454}. |
Q14766 | LTBP1 | S1415 | ochoa | Latent-transforming growth factor beta-binding protein 1 (LTBP-1) (Transforming growth factor beta-1-binding protein 1) (TGF-beta1-BP-1) | Key regulator of transforming growth factor beta (TGFB1, TGFB2 and TGFB3) that controls TGF-beta activation by maintaining it in a latent state during storage in extracellular space (PubMed:2022183, PubMed:8617200, PubMed:8939931). Associates specifically via disulfide bonds with the Latency-associated peptide (LAP), which is the regulatory chain of TGF-beta, and regulates integrin-dependent activation of TGF-beta (PubMed:15184403, PubMed:8617200, PubMed:8939931). Outcompeted by LRRC32/GARP for binding to LAP regulatory chain of TGF-beta (PubMed:22278742). {ECO:0000269|PubMed:15184403, ECO:0000269|PubMed:2022183, ECO:0000269|PubMed:22278742, ECO:0000269|PubMed:8617200, ECO:0000269|PubMed:8939931}. |
Q15283 | RASA2 | S560 | ochoa | Ras GTPase-activating protein 2 (GTPase-activating protein 1m) (GAP1m) | Inhibitory regulator of the Ras-cyclic AMP pathway. Binds inositol tetrakisphosphate (IP4). |
Q15365 | PCBP1 | S264 | ochoa | Poly(rC)-binding protein 1 (Alpha-CP1) (Heterogeneous nuclear ribonucleoprotein E1) (hnRNP E1) (Nucleic acid-binding protein SUB2.3) | Single-stranded nucleic acid binding protein that binds preferentially to oligo dC (PubMed:15731341, PubMed:7556077, PubMed:7607214, PubMed:8152927). Together with PCBP2, required for erythropoiesis, possibly by regulating mRNA splicing (By similarity). {ECO:0000250|UniProtKB:P60335, ECO:0000269|PubMed:15731341, ECO:0000269|PubMed:7556077, ECO:0000269|PubMed:7607214, ECO:0000269|PubMed:8152927}.; FUNCTION: (Microbial infection) In case of infection by poliovirus, plays a role in initiation of viral RNA replication in concert with the viral protein 3CD. {ECO:0000269|PubMed:12414943}. |
Q15366 | PCBP2 | S272 | ochoa|psp | Poly(rC)-binding protein 2 (Alpha-CP2) (Heterogeneous nuclear ribonucleoprotein E2) (hnRNP E2) | Single-stranded nucleic acid binding protein that binds preferentially to oligo dC (PubMed:12414943, PubMed:7607214). Major cellular poly(rC)-binding protein (PubMed:12414943). Also binds poly(rU) (PubMed:12414943). Acts as a negative regulator of antiviral signaling (PubMed:19881509, PubMed:35322803). Negatively regulates cellular antiviral responses mediated by MAVS signaling (PubMed:19881509). It acts as an adapter between MAVS and the E3 ubiquitin ligase ITCH, therefore triggering MAVS ubiquitination and degradation (PubMed:19881509). Negativeley regulates the cGAS-STING pathway via interaction with CGAS, preventing the formation of liquid-like droplets in which CGAS is activated (PubMed:35322803). Together with PCBP1, required for erythropoiesis, possibly by regulating mRNA splicing (By similarity). {ECO:0000250|UniProtKB:Q61990, ECO:0000269|PubMed:12414943, ECO:0000269|PubMed:19881509, ECO:0000269|PubMed:35322803, ECO:0000269|PubMed:7607214}.; FUNCTION: (Microbial infection) In case of infection by poliovirus, binds to the viral internal ribosome entry site (IRES) and stimulates the IRES-mediated translation (PubMed:12414943, PubMed:24371074). Also plays a role in initiation of viral RNA replication in concert with the viral protein 3CD (PubMed:12414943). {ECO:0000269|PubMed:12414943, ECO:0000269|PubMed:24371074}. |
Q2M1Z3 | ARHGAP31 | S382 | ochoa | Rho GTPase-activating protein 31 (Cdc42 GTPase-activating protein) | Functions as a GTPase-activating protein (GAP) for RAC1 and CDC42. Required for cell spreading, polarized lamellipodia formation and cell migration. {ECO:0000269|PubMed:12192056, ECO:0000269|PubMed:16519628}. |
Q3MIW9 | MUCL3 | S126 | ochoa | Mucin-like protein 3 (Diffuse panbronchiolitis critical region protein 1) | May modulate NF-kappaB signaling and play a role in cell growth. {ECO:0000269|PubMed:29242154}. |
Q5BKX6 | SLC45A4 | S411 | ochoa | Solute carrier family 45 member 4 | Proton-associated sucrose transporter. May be able to transport also glucose and fructose. {ECO:0000250|UniProtKB:Q0P5V9}. |
Q5JSH3 | WDR44 | S197 | ochoa | WD repeat-containing protein 44 (Rab11-binding protein) (Rab11BP) (Rabphilin-11) | Downstream effector for Rab11 which regulates Rab11 intracellular membrane trafficking functions such as endocytic recycling, intracellular ciliogenesis and protein export (PubMed:31204173, PubMed:32344433). ATK1-mediated phosphorylation of WDR44 induces binding to Rab11 which activates endocytic recycling of transferrin receptor back to the plasma membrane (PubMed:31204173). When bound to Rab11, prevents the formation of the ciliogenic Rab11-Rabin8/RAB3IP-RAB11FIP3 complex, therefore inhibiting preciliary trafficking and ciliogenesis (PubMed:31204173). Participates in neo-synthesized protein export by connecting the endoplasmic reticulum (ER) with the endosomal tubule via direct interactions with the integral ER proteins VAPA or VAPB and the endosomal protein GRAFs (GRAF1/ARHGAP26 or GRAF2/ARHGAP10), which facilitates the transfer of proteins such as E-cadherin, MPP14 and CFTR into a Rab8-Rab10-Rab11-dependent export route (PubMed:32344433). {ECO:0000269|PubMed:31204173, ECO:0000269|PubMed:32344433}. |
Q5T8D3 | ACBD5 | S257 | ochoa | Acyl-CoA-binding domain-containing protein 5 | Acyl-CoA binding protein which acts as the peroxisome receptor for pexophagy but is dispensable for aggrephagy and nonselective autophagy. Binds medium- and long-chain acyl-CoA esters. {ECO:0000269|PubMed:24535825}. |
Q5TGY3 | AHDC1 | S1191 | ochoa | Transcription factor Gibbin (AT-hook DNA-binding motif-containing protein 1) | Transcription factor required for the proper patterning of the epidermis, which plays a key role in early epithelial morphogenesis (PubMed:35585237). Directly binds promoter and enhancer regions and acts by maintaining local enhancer-promoter chromatin architecture (PubMed:35585237). Interacts with many sequence-specific zinc-finger transcription factors and methyl-CpG-binding proteins to regulate the expression of mesoderm genes that wire surface ectoderm stratification (PubMed:35585237). {ECO:0000269|PubMed:35585237}. |
Q5TH69 | ARFGEF3 | S1651 | ochoa | Brefeldin A-inhibited guanine nucleotide-exchange protein 3 (ARFGEF family member 3) | Participates in the regulation of systemic glucose homeostasis, where it negatively regulates insulin granule biogenesis in pancreatic islet beta cells (By similarity). Also regulates glucagon granule production in pancreatic alpha cells (By similarity). Inhibits nuclear translocation of the transcriptional coregulator PHB2 and may enhance estrogen receptor alpha (ESR1) transcriptional activity in breast cancer cells (PubMed:19496786). {ECO:0000250|UniProtKB:Q3UGY8, ECO:0000269|PubMed:19496786}. |
Q5UIP0 | RIF1 | S1526 | ochoa | Telomere-associated protein RIF1 (Rap1-interacting factor 1 homolog) | Key regulator of TP53BP1 that plays a key role in the repair of double-strand DNA breaks (DSBs) in response to DNA damage: acts by promoting non-homologous end joining (NHEJ)-mediated repair of DSBs (PubMed:15342490, PubMed:28241136). In response to DNA damage, interacts with ATM-phosphorylated TP53BP1 (PubMed:23333306, PubMed:28241136). Interaction with TP53BP1 leads to dissociate the interaction between NUDT16L1/TIRR and TP53BP1, thereby unmasking the tandem Tudor-like domain of TP53BP1 and allowing recruitment to DNA DSBs (PubMed:28241136). Once recruited to DSBs, RIF1 and TP53BP1 act by promoting NHEJ-mediated repair of DSBs (PubMed:23333306). In the same time, RIF1 and TP53BP1 specifically counteract the function of BRCA1 by blocking DSBs resection via homologous recombination (HR) during G1 phase (PubMed:23333306). Also required for immunoglobulin class-switch recombination (CSR) during antibody genesis, a process that involves the generation of DNA DSBs (By similarity). Promotes NHEJ of dysfunctional telomeres (By similarity). {ECO:0000250|UniProtKB:Q6PR54, ECO:0000269|PubMed:15342490, ECO:0000269|PubMed:23333306, ECO:0000269|PubMed:28241136}. |
Q5VWN6 | TASOR2 | S1722 | ochoa | Protein TASOR 2 | None |
Q5XKK7 | FAM219B | S140 | ochoa | Protein FAM219B | None |
Q641Q2 | WASHC2A | S1144 | ochoa | WASH complex subunit 2A | Acts at least in part as component of the WASH core complex whose assembly at the surface of endosomes inhibits WASH nucleation-promoting factor (NPF) activity in recruiting and activating the Arp2/3 complex to induce actin polymerization and is involved in the fission of tubules that serve as transport intermediates during endosome sorting. Mediates the recruitment of the WASH core complex to endosome membranes via binding to phospholipids and VPS35 of the retromer CSC. Mediates the recruitment of the F-actin-capping protein dimer to the WASH core complex probably promoting localized F-actin polymerization needed for vesicle scission. Via its C-terminus binds various phospholipids, most strongly phosphatidylinositol 4-phosphate (PtdIns-(4)P), phosphatidylinositol 5-phosphate (PtdIns-(5)P) and phosphatidylinositol 3,5-bisphosphate (PtdIns-(3,5)P2). Involved in the endosome-to-plasma membrane trafficking and recycling of SNX27-retromer-dependent cargo proteins, such as GLUT1. Required for the association of DNAJC13, ENTR1, ANKRD50 with retromer CSC subunit VPS35. Required for the endosomal recruitment of CCC complex subunits COMMD1 and CCDC93 as well as the retriever complex subunit VPS35L. {ECO:0000269|PubMed:25355947, ECO:0000269|PubMed:28892079}. |
Q69YN4 | VIRMA | S1603 | ochoa | Protein virilizer homolog | Associated component of the WMM complex, a complex that mediates N6-methyladenosine (m6A) methylation of RNAs, a modification that plays a role in the efficiency of mRNA splicing and RNA processing (PubMed:24981863, PubMed:29507755). Acts as a key regulator of m6A methylation by promoting m6A methylation of mRNAs in the 3'-UTR near the stop codon: recruits the catalytic core components METTL3 and METTL14, thereby guiding m6A methylation at specific sites (PubMed:29507755). Required for mRNA polyadenylation via its role in selective m6A methylation: m6A methylation of mRNAs in the 3'-UTR near the stop codon correlating with alternative polyadenylation (APA) (PubMed:29507755). {ECO:0000269|PubMed:24981863, ECO:0000269|PubMed:29507755}. |
Q6DN90 | IQSEC1 | S925 | ochoa | IQ motif and SEC7 domain-containing protein 1 (ADP-ribosylation factors guanine nucleotide-exchange protein 100) (ADP-ribosylation factors guanine nucleotide-exchange protein 2) (Brefeldin-resistant Arf-GEF 2 protein) (BRAG2) | Guanine nucleotide exchange factor for ARF1 and ARF6 (PubMed:11226253, PubMed:24058294). Guanine nucleotide exchange factor activity is enhanced by lipid binding (PubMed:24058294). Accelerates GTP binding by ARFs of all three classes. Guanine nucleotide exchange protein for ARF6, mediating internalization of beta-1 integrin (PubMed:16461286). Involved in neuronal development (Probable). In neurons, plays a role in the control of vesicle formation by endocytoc cargo. Upon long term depression, interacts with GRIA2 and mediates the activation of ARF6 to internalize synaptic AMPAR receptors (By similarity). {ECO:0000250|UniProtKB:A0A0G2JUG7, ECO:0000269|PubMed:11226253, ECO:0000269|PubMed:16461286, ECO:0000269|PubMed:24058294, ECO:0000305|PubMed:31607425}. |
Q6VUC0 | TFAP2E | T231 | ochoa | Transcription factor AP-2-epsilon (AP2-epsilon) (Activating enhancer-binding protein 2-epsilon) | Sequence-specific DNA-binding protein that interacts with inducible viral and cellular enhancer elements to regulate transcription of selected genes. AP-2 factors bind to the consensus sequence 5'-GCCNNNGGC-3' and activate genes involved in a large spectrum of important biological functions including proper eye, face, body wall, limb and neural tube development. They also suppress a number of genes including MCAM/MUC18, C/EBP alpha and MYC. AP-2-epsilon may play a role in the development of the CNS and in cartilage differentiation (By similarity). {ECO:0000250}. |
Q6ZU80 | CEP128 | S1043 | ochoa | Centrosomal protein of 128 kDa (Cep128) | None |
Q7Z417 | NUFIP2 | S113 | ochoa | FMR1-interacting protein NUFIP2 (82 kDa FMRP-interacting protein) (82-FIP) (Cell proliferation-inducing gene 1 protein) (FMRP-interacting protein 2) (Nuclear FMR1-interacting protein 2) | Binds RNA. {ECO:0000269|PubMed:12837692}. |
Q7Z5H3 | ARHGAP22 | S395 | ochoa|psp | Rho GTPase-activating protein 22 (Rho-type GTPase-activating protein 22) | Rho GTPase-activating protein involved in the signal transduction pathway that regulates endothelial cell capillary tube formation during angiogenesis. Acts as a GTPase activator for the RAC1 by converting it to an inactive GDP-bound state. Inhibits RAC1-dependent lamellipodia formation. May also play a role in transcription regulation via its interaction with VEZF1, by regulating activity of the endothelin-1 (EDN1) promoter (By similarity). {ECO:0000250}. |
Q8IWE2 | FAM114A1 | S140 | ochoa | Protein NOXP20 (Nervous system overexpressed protein 20) (Protein FAM114A1) | May play a role in neuronal cell development. {ECO:0000250}. |
Q8IY63 | AMOTL1 | S787 | ochoa | Angiomotin-like protein 1 | Inhibits the Wnt/beta-catenin signaling pathway, probably by recruiting CTNNB1 to recycling endosomes and hence preventing its translocation to the nucleus. {ECO:0000269|PubMed:22362771}. |
Q8N0X7 | SPART | S394 | ochoa | Spartin (Spastic paraplegia 20 protein) (Trans-activated by hepatitis C virus core protein 1) | Lipophagy receptor that plays an important role in lipid droplet (LD) turnover in motor neurons (PubMed:37443287). Localizes to LDs and interacts with components of the autophagy machinery, such as MAP1LC3A/C proteins to deliver LDs to autophagosomes for degradation via lipophagy (PubMed:37443287). Lipid transfer protein required for lipid droplet degradation, including by lipophagy (PubMed:38190532). Can bind and transfer all lipid species found in lipid droplets, from phospholipids to triglycerides and sterol esters but the direction of lipid transfer by spartin and its cargos are unknown (PubMed:38190532). May be implicated in endosomal trafficking, or microtubule dynamics, or both. Participates in cytokinesis (PubMed:20719964). {ECO:0000269|PubMed:20719964, ECO:0000269|PubMed:37443287, ECO:0000269|PubMed:38190532}. |
Q8N1W1 | ARHGEF28 | S736 | ochoa | Rho guanine nucleotide exchange factor 28 (190 kDa guanine nucleotide exchange factor) (p190-RhoGEF) (p190RhoGEF) (Rho guanine nucleotide exchange factor) | Functions as a RHOA-specific guanine nucleotide exchange factor regulating signaling pathways downstream of integrins and growth factor receptors. Functions in axonal branching, synapse formation and dendritic morphogenesis. Also functions in focal adhesion formation, cell motility and B-lymphocytes activation. May regulate NEFL expression and aggregation and play a role in apoptosis (By similarity). {ECO:0000250}. |
Q8N697 | SLC15A4 | S291 | ochoa | Solute carrier family 15 member 4 (Peptide transporter 4) (Peptide/histidine transporter 1) (hPHT1) | Proton-coupled amino-acid transporter that mediates the transmembrane transport of L-histidine and some di- and tripeptides from inside the lysosome to the cytosol, and plays a key role in innate immune response (PubMed:16289537, PubMed:25238095, PubMed:29224352). Able to transport a variety of di- and tripeptides, including carnosine and some peptidoglycans (PubMed:29224352, PubMed:31073693). Transporter activity is pH-dependent and maximized in the acidic lysosomal environment (By similarity). Involved in the detection of microbial pathogens by toll-like receptors (TLRs) and NOD-like receptors (NLRs), probably by mediating transport of bacterial peptidoglycans across the endolysosomal membrane: catalyzes the transport of certain bacterial peptidoglycans, such as muramyl dipeptide (MDP), the NOD2 ligand, and L-alanyl-gamma-D-glutamyl-meso-2,6-diaminoheptanedioate (tri-DAP), the NOD1 ligand (PubMed:25238095, PubMed:29224352). Required for TLR7, TLR8 and TLR9-mediated type I interferon (IFN-I) productions in plasmacytoid dendritic cells (pDCs) (PubMed:25238095). Independently of its transporter activity, also promotes the recruitment of innate immune adapter TASL to endolysosome downstream of TLR7, TLR8 and TLR9: TASL recruitment leads to the specific recruitment and activation of IRF5 (PubMed:32433612). Required for isotype class switch recombination to IgG2c isotype in response to TLR9 stimulation (By similarity). Required for mast cell secretory-granule homeostasis by limiting mast cell functions and inflammatory responses (By similarity). {ECO:0000250|UniProtKB:O09014, ECO:0000250|UniProtKB:Q91W98, ECO:0000269|PubMed:16289537, ECO:0000269|PubMed:25238095, ECO:0000269|PubMed:29224352, ECO:0000269|PubMed:31073693, ECO:0000269|PubMed:32433612}. |
Q8NE79 | POPDC1 | S318 | ochoa | Popeye domain-containing protein 1 (Popeye protein 1) | Cell adhesion molecule involved in the establishment and/or maintenance of cell integrity. Involved in the formation and regulation of the tight junction (TJ) paracellular permeability barrier in epithelial cells (PubMed:16188940). Plays a role in VAMP3-mediated vesicular transport and recycling of different receptor molecules through its interaction with VAMP3. Plays a role in the regulation of cell shape and movement by modulating the Rho-family GTPase activity through its interaction with ARHGEF25/GEFT. Induces primordial adhesive contact and aggregation of epithelial cells in a Ca(2+)-independent manner. Also involved in striated muscle regeneration and repair and in the regulation of cell spreading (By similarity). Important for the maintenance of cardiac function. Plays a regulatory function in heart rate dynamics mediated, at least in part, through cAMP-binding and, probably, by increasing cell surface expression of the potassium channel KCNK2 and enhancing current density (PubMed:26642364). Is also a caveolae-associated protein important for the preservation of caveolae structural and functional integrity as well as for heart protection against ischemia injury. {ECO:0000250|UniProtKB:Q5PQZ7, ECO:0000250|UniProtKB:Q9ES83, ECO:0000269|PubMed:16188940, ECO:0000269|PubMed:26642364}. |
Q8NFC6 | BOD1L1 | S2909 | ochoa | Biorientation of chromosomes in cell division protein 1-like 1 | Component of the fork protection machinery required to protect stalled/damaged replication forks from uncontrolled DNA2-dependent resection. Acts by stabilizing RAD51 at stalled replication forks and protecting RAD51 nucleofilaments from the antirecombinogenic activities of FBH1 and BLM (PubMed:26166705, PubMed:29937342). Does not regulate spindle orientation (PubMed:26166705). {ECO:0000269|PubMed:26166705, ECO:0000269|PubMed:29937342}. |
Q8NHZ8 | CDC26 | S52 | ochoa | Anaphase-promoting complex subunit CDC26 (Anaphase-promoting complex subunit 12) (APC12) (Cell division cycle protein 26 homolog) | Component of the anaphase promoting complex/cyclosome (APC/C), a cell cycle-regulated E3 ubiquitin ligase that controls progression through mitosis and the G1 phase of the cell cycle (PubMed:18485873). The APC/C complex acts by mediating ubiquitination and subsequent degradation of target proteins: it mainly mediates the formation of 'Lys-11'-linked polyubiquitin chains and, to a lower extent, the formation of 'Lys-48'- and 'Lys-63'-linked polyubiquitin chains (PubMed:18485873). The APC/C complex catalyzes assembly of branched 'Lys-11'-/'Lys-48'-linked branched ubiquitin chains on target proteins (PubMed:29033132). May recruit the E2 ubiquitin-conjugating enzymes to the complex (PubMed:18485873). {ECO:0000269|PubMed:18485873, ECO:0000269|PubMed:29033132}. |
Q8TEW8 | PARD3B | S746 | ochoa|psp | Partitioning defective 3 homolog B (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 19 protein) (PAR3-beta) (Partitioning defective 3-like protein) (PAR3-L protein) | Putative adapter protein involved in asymmetrical cell division and cell polarization processes. May play a role in the formation of epithelial tight junctions. |
Q8TF72 | SHROOM3 | S664 | ochoa | Protein Shroom3 (Shroom-related protein) (hShrmL) | Controls cell shape changes in the neuroepithelium during neural tube closure. Induces apical constriction in epithelial cells by promoting the apical accumulation of F-actin and myosin II, and probably by bundling stress fibers (By similarity). Induces apicobasal cell elongation by redistributing gamma-tubulin and directing the assembly of robust apicobasal microtubule arrays (By similarity). {ECO:0000250|UniProtKB:Q27IV2, ECO:0000250|UniProtKB:Q9QXN0}. |
Q8WXI7 | MUC16 | S9580 | ochoa | Mucin-16 (MUC-16) (Ovarian cancer-related tumor marker CA125) (CA-125) (Ovarian carcinoma antigen CA125) | Thought to provide a protective, lubricating barrier against particles and infectious agents at mucosal surfaces. {ECO:0000250}. |
Q92481 | TFAP2B | T243 | ochoa | Transcription factor AP-2-beta (AP2-beta) (Activating enhancer-binding protein 2-beta) | Sequence-specific DNA-binding protein that interacts with inducible viral and cellular enhancer elements to regulate transcription of selected genes. AP-2 factors bind to the consensus sequence 5'-GCCNNNGGC-3' and activate genes involved in a large spectrum of important biological functions including proper eye, face, body wall, limb and neural tube development. They also suppress a number of genes including MCAM/MUC18, C/EBP alpha and MYC. AP-2-beta appears to be required for normal face and limb development and for proper terminal differentiation and function of renal tubular epithelia. {ECO:0000269|PubMed:11694877}. |
Q92574 | TSC1 | S539 | ochoa | Hamartin (Tuberous sclerosis 1 protein) | Non-catalytic component of the TSC-TBC complex, a multiprotein complex that acts as a negative regulator of the canonical mTORC1 complex, an evolutionarily conserved central nutrient sensor that stimulates anabolic reactions and macromolecule biosynthesis to promote cellular biomass generation and growth (PubMed:12172553, PubMed:12271141, PubMed:12906785, PubMed:15340059, PubMed:24529379, PubMed:28215400). The TSC-TBC complex acts as a GTPase-activating protein (GAP) for the small GTPase RHEB, a direct activator of the protein kinase activity of mTORC1 (PubMed:12906785, PubMed:15340059, PubMed:24529379). In absence of nutrients, the TSC-TBC complex inhibits mTORC1, thereby preventing phosphorylation of ribosomal protein S6 kinase (RPS6KB1 and RPS6KB2) and EIF4EBP1 (4E-BP1) by the mTORC1 signaling (PubMed:12271141, PubMed:24529379, PubMed:28215400, PubMed:33215753). The TSC-TBC complex is inactivated in response to nutrients, relieving inhibition of mTORC1 (PubMed:12172553, PubMed:24529379). Within the TSC-TBC complex, TSC1 stabilizes TSC2 and prevents TSC2 self-aggregation (PubMed:10585443, PubMed:28215400). Acts as a tumor suppressor (PubMed:9242607). Involved in microtubule-mediated protein transport via its ability to regulate mTORC1 signaling (By similarity). Also acts as a co-chaperone for HSP90AA1 facilitating HSP90AA1 chaperoning of protein clients such as kinases, TSC2 and glucocorticoid receptor NR3C1 (PubMed:29127155). Increases ATP binding to HSP90AA1 and inhibits HSP90AA1 ATPase activity (PubMed:29127155). Competes with the activating co-chaperone AHSA1 for binding to HSP90AA1, thereby providing a reciprocal regulatory mechanism for chaperoning of client proteins (PubMed:29127155). Recruits TSC2 to HSP90AA1 and stabilizes TSC2 by preventing the interaction between TSC2 and ubiquitin ligase HERC1 (PubMed:16464865, PubMed:29127155). {ECO:0000250|UniProtKB:Q9Z136, ECO:0000269|PubMed:10585443, ECO:0000269|PubMed:12172553, ECO:0000269|PubMed:12271141, ECO:0000269|PubMed:12906785, ECO:0000269|PubMed:15340059, ECO:0000269|PubMed:16464865, ECO:0000269|PubMed:24529379, ECO:0000269|PubMed:28215400, ECO:0000269|PubMed:29127155, ECO:0000269|PubMed:33215753, ECO:0000269|PubMed:9242607}. |
Q92754 | TFAP2C | T237 | ochoa | Transcription factor AP-2 gamma (AP2-gamma) (Activating enhancer-binding protein 2 gamma) (Transcription factor ERF-1) | Sequence-specific DNA-binding transcription factor that interacts with cellular enhancer elements to regulate transcription of selected genes, and which plays a key role in early embryonic development (PubMed:11694877, PubMed:24413532). AP-2 factors bind to the consensus sequence 5'-GCCNNNGGC-3' and activate genes involved in a large spectrum of important biological functions (PubMed:11694877, PubMed:24413532). TFAP2C plays a key role in early embryonic development by regulating both inner cell mass (ICM) and trophectoderm differentiation (By similarity). At the 8-cell stage, during morula development, controls expression of cell-polarity genes (By similarity). Upon trophoblast commitment, binds to late trophectoderm genes in blastocysts together with CDX2, and later to extra-embryonic ectoderm genes together with SOX2 (By similarity). Binds to both closed and open chromatin with other transcription factors (By similarity). Involved in the MTA1-mediated epigenetic regulation of ESR1 expression in breast cancer (PubMed:24413532). {ECO:0000250|UniProtKB:Q61312, ECO:0000269|PubMed:11694877, ECO:0000269|PubMed:24413532}. |
Q96B97 | SH3KBP1 | S445 | ochoa | SH3 domain-containing kinase-binding protein 1 (CD2-binding protein 3) (CD2BP3) (Cbl-interacting protein of 85 kDa) (Human Src family kinase-binding protein 1) (HSB-1) | Adapter protein involved in regulating diverse signal transduction pathways. Involved in the regulation of endocytosis and lysosomal degradation of ligand-induced receptor tyrosine kinases, including EGFR and MET/hepatocyte growth factor receptor, through an association with CBL and endophilins. The association with CBL, and thus the receptor internalization, may be inhibited by an interaction with PDCD6IP and/or SPRY2. Involved in regulation of ligand-dependent endocytosis of the IgE receptor. Attenuates phosphatidylinositol 3-kinase activity by interaction with its regulatory subunit (By similarity). May be involved in regulation of cell adhesion; promotes the interaction between TTK2B and PDCD6IP. May be involved in the regulation of cellular stress response via the MAPK pathways through its interaction with MAP3K4. Is involved in modulation of tumor necrosis factor mediated apoptosis. Plays a role in the regulation of cell morphology and cytoskeletal organization. Required in the control of cell shape and migration. Has an essential role in the stimulation of B cell activation (PubMed:29636373). {ECO:0000250, ECO:0000269|PubMed:11894095, ECO:0000269|PubMed:11894096, ECO:0000269|PubMed:12177062, ECO:0000269|PubMed:12734385, ECO:0000269|PubMed:12771190, ECO:0000269|PubMed:15090612, ECO:0000269|PubMed:15707590, ECO:0000269|PubMed:16177060, ECO:0000269|PubMed:16256071, ECO:0000269|PubMed:21275903, ECO:0000269|PubMed:21834987, ECO:0000269|PubMed:29636373}. |
Q96DY7 | MTBP | S547 | ochoa | Mdm2-binding protein (hMTBP) | Inhibits cell migration in vitro and suppresses the invasive behavior of tumor cells (By similarity). May play a role in MDM2-dependent p53/TP53 homeostasis in unstressed cells. Inhibits autoubiquitination of MDM2, thereby enhancing MDM2 stability. This promotes MDM2-mediated ubiquitination of p53/TP53 and its subsequent degradation. {ECO:0000250, ECO:0000269|PubMed:15632057}. |
Q9BST9 | RTKN | S220 | ochoa | Rhotekin | Mediates Rho signaling to activate NF-kappa-B and may confer increased resistance to apoptosis to cells in gastric tumorigenesis. May play a novel role in the organization of septin structures. {ECO:0000269|PubMed:10940294, ECO:0000269|PubMed:15480428, ECO:0000269|PubMed:16007136}. |
Q9BT25 | HAUS8 | S21 | ochoa|psp | HAUS augmin-like complex subunit 8 (HEC1/NDC80-interacting centrosome-associated protein 1) (Sarcoma antigen NY-SAR-48) | Contributes to mitotic spindle assembly, maintenance of centrosome integrity and completion of cytokinesis as part of the HAUS augmin-like complex. {ECO:0000269|PubMed:18362163, ECO:0000269|PubMed:19369198, ECO:0000269|PubMed:19427217}. |
Q9BUF5 | TUBB6 | Y340 | ochoa | Tubulin beta-6 chain (Tubulin beta class V) | Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers. Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin. {ECO:0000250|UniProtKB:P02557}. |
Q9BV23 | ABHD6 | S115 | ochoa | Monoacylglycerol lipase ABHD6 (EC 3.1.1.23) (2-arachidonoylglycerol hydrolase) (Abhydrolase domain-containing protein 6) | Lipase that preferentially hydrolysis medium-chain saturated monoacylglycerols including 2-arachidonoylglycerol (PubMed:22969151). Through 2-arachidonoylglycerol degradation may regulate endocannabinoid signaling pathways (By similarity). Also has a lysophosphatidyl lipase activity with a preference for lysophosphatidylglycerol among other lysophospholipids (By similarity). Also able to degrade bis(monoacylglycero)phosphate (BMP) and constitutes the major enzyme for BMP catabolism (PubMed:26491015). BMP, also known as lysobisphosphatidic acid, is enriched in late endosomes and lysosomes and plays a key role in the formation of intraluminal vesicles and in lipid sorting (PubMed:26491015). {ECO:0000250|UniProtKB:Q8R2Y0, ECO:0000269|PubMed:22969151, ECO:0000269|PubMed:26491015}. |
Q9BVA1 | TUBB2B | Y340 | ochoa | Tubulin beta-2B chain | Tubulin is the major constituent of microtubules, a cylinder consisting of laterally associated linear protofilaments composed of alpha- and beta-tubulin heterodimers (PubMed:23001566, PubMed:26732629, PubMed:28013290). Microtubules grow by the addition of GTP-tubulin dimers to the microtubule end, where a stabilizing cap forms. Below the cap, tubulin dimers are in GDP-bound state, owing to GTPase activity of alpha-tubulin. Plays a critical role in proper axon guidance in both central and peripheral axon tracts (PubMed:23001566). Implicated in neuronal migration (PubMed:19465910). {ECO:0000269|PubMed:19465910, ECO:0000269|PubMed:23001566, ECO:0000269|PubMed:26732629, ECO:0000269|PubMed:28013290}. |
Q9GZV4 | EIF5A2 | S46 | ochoa | Eukaryotic translation initiation factor 5A-2 (eIF-5A-2) (eIF-5A2) (Eukaryotic initiation factor 5A isoform 2) | Translation factor that promotes translation elongation and termination, particularly upon ribosome stalling at specific amino acid sequence contexts (PubMed:14622290). Binds between the exit (E) and peptidyl (P) site of the ribosome and promotes rescue of stalled ribosome: specifically required for efficient translation of polyproline-containing peptides as well as other motifs that stall the ribosome. Acts as a ribosome quality control (RQC) cofactor by joining the RQC complex to facilitate peptidyl transfer during CAT tailing step (By similarity). Also involved in actin dynamics and cell cycle progression, mRNA decay and probably in a pathway involved in stress response and maintenance of cell wall integrity (By similarity). {ECO:0000250|UniProtKB:P23301, ECO:0000250|UniProtKB:P63241, ECO:0000269|PubMed:14622290}. |
Q9GZZ9 | UBA5 | S45 | ochoa | Ubiquitin-like modifier-activating enzyme 5 (Ubiquitin-activating enzyme 5) (ThiFP1) (UFM1-activating enzyme) (Ubiquitin-activating enzyme E1 domain-containing protein 1) | E1-like enzyme which specifically catalyzes the first step in ufmylation (PubMed:15071506, PubMed:18442052, PubMed:20368332, PubMed:25219498, PubMed:26929408, PubMed:27545674, PubMed:27545681, PubMed:27653677, PubMed:30412706, PubMed:30626644, PubMed:34588452). Activates UFM1 by first adenylating its C-terminal glycine residue with ATP, and thereafter linking this residue to the side chain of a cysteine residue in E1, yielding a UFM1-E1 thioester and free AMP (PubMed:20368332, PubMed:26929408, PubMed:27653677, PubMed:30412706). Activates UFM1 via a trans-binding mechanism, in which UFM1 interacts with distinct sites in both subunits of the UBA5 homodimer (PubMed:27653677). Trans-binding also promotes stabilization of the UBA5 homodimer, and enhances ATP-binding (PubMed:29295865). Transfer of UFM1 from UBA5 to the E2-like enzyme UFC1 also takes place using a trans mechanism (PubMed:27653677, PubMed:34588452). Ufmylation plays a key role in various processes, such as ribosome recycling, response to DNA damage, interferon response or reticulophagy (also called ER-phagy) (PubMed:30412706, PubMed:32160526, PubMed:35394863). Ufmylation is essential for erythroid differentiation of both megakaryocytes and erythrocytes (By similarity). {ECO:0000250|UniProtKB:Q8VE47, ECO:0000269|PubMed:15071506, ECO:0000269|PubMed:18442052, ECO:0000269|PubMed:20368332, ECO:0000269|PubMed:25219498, ECO:0000269|PubMed:26929408, ECO:0000269|PubMed:27545674, ECO:0000269|PubMed:27545681, ECO:0000269|PubMed:27653677, ECO:0000269|PubMed:29295865, ECO:0000269|PubMed:30412706, ECO:0000269|PubMed:30626644, ECO:0000269|PubMed:32160526, ECO:0000269|PubMed:34588452, ECO:0000269|PubMed:35394863}. |
Q9H1B7 | IRF2BPL | S337 | ochoa | Probable E3 ubiquitin-protein ligase IRF2BPL (EC 2.3.2.27) (Enhanced at puberty protein 1) (Interferon regulatory factor 2-binding protein-like) | Probable E3 ubiquitin protein ligase involved in the proteasome-mediated ubiquitin-dependent degradation of target proteins (PubMed:29374064). Through the degradation of CTNNB1, functions downstream of FOXF2 to negatively regulate the Wnt signaling pathway (PubMed:29374064). Probably plays a role in the development of the central nervous system and in neuronal maintenance (Probable). Also acts as a transcriptional regulator of genes controlling female reproductive function. May play a role in gene transcription by transactivating GNRH1 promoter and repressing PENK promoter (By similarity). {ECO:0000250|UniProtKB:Q5EIC4, ECO:0000269|PubMed:29374064, ECO:0000305|PubMed:17334524, ECO:0000305|PubMed:29374064, ECO:0000305|PubMed:30057031}. |
Q9H4L5 | OSBPL3 | S173 | ochoa | Oxysterol-binding protein-related protein 3 (ORP-3) (OSBP-related protein 3) | Phosphoinositide-binding protein which associates with both cell and endoplasmic reticulum (ER) membranes (PubMed:16143324). Can bind to the ER membrane protein VAPA and recruit VAPA to plasma membrane sites, thus linking these intracellular compartments (PubMed:25447204). The ORP3-VAPA complex stimulates RRAS signaling which in turn attenuates integrin beta-1 (ITGB1) activation at the cell surface (PubMed:18270267, PubMed:25447204). With VAPA, may regulate ER morphology (PubMed:16143324). Has a role in regulation of the actin cytoskeleton, cell polarity and cell adhesion (PubMed:18270267). Binds to phosphoinositides with preference for PI(3,4)P2 and PI(3,4,5)P3 (PubMed:16143324). Also binds 25-hydroxycholesterol and cholesterol (PubMed:17428193). {ECO:0000269|PubMed:16143324, ECO:0000269|PubMed:17428193, ECO:0000269|PubMed:18270267, ECO:0000269|PubMed:25447204}. |
Q9H582 | ZNF644 | S124 | ochoa | Zinc finger protein 644 (Zinc finger motif enhancer-binding protein 2) (Zep-2) | May be involved in transcriptional regulation. |
Q9H7N4 | SCAF1 | S941 | ochoa | Splicing factor, arginine/serine-rich 19 (SR-related C-terminal domain-associated factor 1) (SR-related and CTD-associated factor 1) (SR-related-CTD-associated factor) (SCAF) (Serine arginine-rich pre-mRNA splicing factor SR-A1) (SR-A1) | May function in pre-mRNA splicing. {ECO:0000250}. |
Q9NRR3 | CDC42SE2 | S55 | ochoa | CDC42 small effector protein 2 (Small effector of CDC42 protein 2) | Probably involved in the organization of the actin cytoskeleton by acting downstream of CDC42, inducing actin filament assembly. Alters CDC42-induced cell shape changes. In activated T-cells, may play a role in CDC42-mediated F-actin accumulation at the immunological synapse. May play a role in early contractile events in phagocytosis in macrophages. {ECO:0000269|PubMed:10816584, ECO:0000269|PubMed:15840583}. |
Q9NRY4 | ARHGAP35 | S1142 | ochoa | Rho GTPase-activating protein 35 (Glucocorticoid receptor DNA-binding factor 1) (Glucocorticoid receptor repression factor 1) (GRF-1) (Rho GAP p190A) (p190-A) | Rho GTPase-activating protein (GAP) (PubMed:19673492, PubMed:28894085). Binds several acidic phospholipids which inhibits the Rho GAP activity to promote the Rac GAP activity (PubMed:19673492). This binding is inhibited by phosphorylation by PRKCA (PubMed:19673492). Involved in cell differentiation as well as cell adhesion and migration, plays an important role in retinal tissue morphogenesis, neural tube fusion, midline fusion of the cerebral hemispheres and mammary gland branching morphogenesis (By similarity). Transduces signals from p21-ras to the nucleus, acting via the ras GTPase-activating protein (GAP) (By similarity). Transduces SRC-dependent signals from cell-surface adhesion molecules, such as laminin, to promote neurite outgrowth. Regulates axon outgrowth, guidance and fasciculation (By similarity). Modulates Rho GTPase-dependent F-actin polymerization, organization and assembly, is involved in polarized cell migration and in the positive regulation of ciliogenesis and cilia elongation (By similarity). During mammary gland development, is required in both the epithelial and stromal compartments for ductal outgrowth (By similarity). Represses transcription of the glucocorticoid receptor by binding to the cis-acting regulatory sequence 5'-GAGAAAAGAAACTGGAGAAACTC-3'; this function is however unclear and would need additional experimental evidences (PubMed:1894621). {ECO:0000250|UniProtKB:P81128, ECO:0000250|UniProtKB:Q91YM2, ECO:0000269|PubMed:1894621, ECO:0000269|PubMed:19673492, ECO:0000269|PubMed:28894085}. |
Q9NV70 | EXOC1 | S473 | ochoa | Exocyst complex component 1 (Exocyst complex component Sec3) | Component of the exocyst complex involved in the docking of exocytic vesicles with fusion sites on the plasma membrane.; FUNCTION: (Microbial infection) Has an antiviral effect against flaviviruses by affecting viral RNA transcription and translation through the sequestration of elongation factor 1-alpha (EEF1A1). This results in decreased viral RNA synthesis and decreased viral protein translation. {ECO:0000269|PubMed:19889084}. |
Q9P0U3 | SENP1 | S108 | ochoa | Sentrin-specific protease 1 (EC 3.4.22.-) (Sentrin/SUMO-specific protease SENP1) | Protease that catalyzes two essential functions in the SUMO pathway (PubMed:10652325, PubMed:15199155, PubMed:15487983, PubMed:16253240, PubMed:16553580, PubMed:21829689, PubMed:21965678, PubMed:23160374, PubMed:24943844, PubMed:25406032, PubMed:29506078, PubMed:34048572, PubMed:37257451). The first is the hydrolysis of an alpha-linked peptide bond at the C-terminal end of the small ubiquitin-like modifier (SUMO) propeptides, SUMO1, SUMO2 and SUMO3 leading to the mature form of the proteins (PubMed:15487983). The second is the deconjugation of SUMO1, SUMO2 and SUMO3 from targeted proteins, by cleaving an epsilon-linked peptide bond between the C-terminal glycine of the mature SUMO and the lysine epsilon-amino group of the target protein (PubMed:15199155, PubMed:16253240, PubMed:21829689, PubMed:21965678, PubMed:23160374, PubMed:24943844, PubMed:25406032, PubMed:29506078, PubMed:34048572, PubMed:37257451). Deconjugates SUMO1 from HIPK2 (PubMed:16253240). Deconjugates SUMO1 from HDAC1 and BHLHE40/DEC1, which decreases its transcriptional repression activity (PubMed:15199155, PubMed:21829689). Deconjugates SUMO1 from CLOCK, which decreases its transcriptional activation activity (PubMed:23160374). Deconjugates SUMO2 from MTA1 (PubMed:21965678). Inhibits N(6)-methyladenosine (m6A) RNA methylation by mediating SUMO1 deconjugation from METTL3 and ALKBH5: METTL3 inhibits the m6A RNA methyltransferase activity, while ALKBH5 desumoylation promotes m6A demethylation (PubMed:29506078, PubMed:34048572, PubMed:37257451). Desumoylates CCAR2 which decreases its interaction with SIRT1 (PubMed:25406032). Deconjugates SUMO1 from GPS2 (PubMed:24943844). {ECO:0000269|PubMed:10652325, ECO:0000269|PubMed:15199155, ECO:0000269|PubMed:15487983, ECO:0000269|PubMed:16253240, ECO:0000269|PubMed:16553580, ECO:0000269|PubMed:21829689, ECO:0000269|PubMed:21965678, ECO:0000269|PubMed:23160374, ECO:0000269|PubMed:24943844, ECO:0000269|PubMed:25406032, ECO:0000269|PubMed:29506078, ECO:0000269|PubMed:34048572, ECO:0000269|PubMed:37257451}. |
Q9P107 | GMIP | S886 | ochoa | GEM-interacting protein (GMIP) | Stimulates, in vitro and in vivo, the GTPase activity of RhoA. {ECO:0000269|PubMed:12093360}. |
Q9UGP4 | LIMD1 | S256 | ochoa | LIM domain-containing protein 1 | Adapter or scaffold protein which participates in the assembly of numerous protein complexes and is involved in several cellular processes such as cell fate determination, cytoskeletal organization, repression of gene transcription, cell-cell adhesion, cell differentiation, proliferation and migration. Positively regulates microRNA (miRNA)-mediated gene silencing and is essential for P-body formation and integrity. Acts as a hypoxic regulator by bridging an association between the prolyl hydroxylases and VHL enabling efficient degradation of HIF1A. Acts as a transcriptional corepressor for SNAI1- and SNAI2/SLUG-dependent repression of E-cadherin transcription. Negatively regulates the Hippo signaling pathway and antagonizes phosphorylation of YAP1. Inhibits E2F-mediated transcription, and suppresses the expression of the majority of genes with E2F1-responsive elements. Regulates osteoblast development, function, differentiation and stress osteoclastogenesis. Enhances the ability of TRAF6 to activate adapter protein complex 1 (AP-1) and negatively regulates the canonical Wnt receptor signaling pathway in osteoblasts. May act as a tumor suppressor by inhibiting cell proliferation. {ECO:0000269|PubMed:15542589, ECO:0000269|PubMed:20303269, ECO:0000269|PubMed:20616046, ECO:0000269|PubMed:21834987, ECO:0000269|PubMed:22286099}. |
Q9UHB7 | AFF4 | S526 | ochoa | AF4/FMR2 family member 4 (ALL1-fused gene from chromosome 5q31 protein) (Protein AF-5q31) (Major CDK9 elongation factor-associated protein) | Key component of the super elongation complex (SEC), a complex required to increase the catalytic rate of RNA polymerase II transcription by suppressing transient pausing by the polymerase at multiple sites along the DNA. In the SEC complex, AFF4 acts as a central scaffold that recruits other factors through direct interactions with ELL proteins (ELL, ELL2 or ELL3) and the P-TEFb complex. In case of infection by HIV-1 virus, the SEC complex is recruited by the viral Tat protein to stimulate viral gene expression. {ECO:0000269|PubMed:20159561, ECO:0000269|PubMed:20471948, ECO:0000269|PubMed:23251033}. |
Q9UHL9 | GTF2IRD1 | S118 | ochoa | General transcription factor II-I repeat domain-containing protein 1 (GTF2I repeat domain-containing protein 1) (General transcription factor III) (MusTRD1/BEN) (Muscle TFII-I repeat domain-containing protein 1) (Slow-muscle-fiber enhancer-binding protein) (USE B1-binding protein) (Williams-Beuren syndrome chromosomal region 11 protein) (Williams-Beuren syndrome chromosomal region 12 protein) | May be a transcription regulator involved in cell-cycle progression and skeletal muscle differentiation. May repress GTF2I transcriptional functions, by preventing its nuclear residency, or by inhibiting its transcriptional activation. May contribute to slow-twitch fiber type specificity during myogenesis and in regenerating muscles. Binds troponin I slow-muscle fiber enhancer (USE B1). Binds specifically and with high affinity to the EFG sequences derived from the early enhancer of HOXC8 (By similarity). {ECO:0000250, ECO:0000269|PubMed:11438732}. |
Q9UJY4 | GGA2 | S327 | ochoa | ADP-ribosylation factor-binding protein GGA2 (Gamma-adaptin-related protein 2) (Golgi-localized, gamma ear-containing, ARF-binding protein 2) (VHS domain and ear domain of gamma-adaptin) (Vear) | Plays a role in protein sorting and trafficking between the trans-Golgi network (TGN) and endosomes. Mediates the ARF-dependent recruitment of clathrin to the TGN and binds ubiquitinated proteins and membrane cargo molecules with a cytosolic acidic cluster-dileucine (DXXLL) motif (PubMed:10747088). Mediates export of the GPCR receptor ADRA2B to the cell surface (PubMed:27901063). Regulates retrograde transport of phosphorylated form of BACE1 from endosomes to the trans-Golgi network (PubMed:15615712). {ECO:0000269|PubMed:10747088, ECO:0000269|PubMed:15615712, ECO:0000269|PubMed:27901063}. |
Q9UK96 | FBXO10 | S326 | ochoa | F-box only protein 10 | Substrate-recognition component of the SCF (SKP1-CUL1-F-box protein)-type E3 ubiquitin ligase complex. Mediates the ubiquitination and degradation of BCL2, an antiapoptotic protein, thereby playing a role in apoptosis by controlling the stability of BCL2. Targets also the receptor for advanced glycation end products RAGE for ubiquitination and subsequent lysosomal degradation (PubMed:28515150). Directly controls HGAL/GCSAM ubiquitination and degradation and thereby decreases BCR signaling (PubMed:31570756). {ECO:0000269|PubMed:23431138, ECO:0000269|PubMed:28515150, ECO:0000269|PubMed:31570756}. |
Q9UKX2 | MYH2 | S649 | ochoa | Myosin-2 (Myosin heavy chain 2) (Myosin heavy chain 2a) (MyHC-2a) (Myosin heavy chain IIa) (MyHC-IIa) (Myosin heavy chain, skeletal muscle, adult 2) | Myosins are actin-based motor molecules with ATPase activity essential for muscle contraction. {ECO:0000250|UniProtKB:P12883}. |
Q9UPY3 | DICER1 | S1142 | ochoa | Endoribonuclease Dicer (EC 3.1.26.3) (Helicase with RNase motif) (Helicase MOI) | Double-stranded RNA (dsRNA) endoribonuclease playing a central role in short dsRNA-mediated post-transcriptional gene silencing. Cleaves naturally occurring long dsRNAs and short hairpin pre-microRNAs (miRNA) into fragments of twenty-one to twenty-three nucleotides with 3' overhang of two nucleotides, producing respectively short interfering RNAs (siRNA) and mature microRNAs. SiRNAs and miRNAs serve as guide to direct the RNA-induced silencing complex (RISC) to complementary RNAs to degrade them or prevent their translation. Gene silencing mediated by siRNAs, also called RNA interference, controls the elimination of transcripts from mobile and repetitive DNA elements of the genome but also the degradation of exogenous RNA of viral origin for instance. The miRNA pathway on the other side is a mean to specifically regulate the expression of target genes. {ECO:0000269|PubMed:15242644, ECO:0000269|PubMed:15973356, ECO:0000269|PubMed:16142218, ECO:0000269|PubMed:16271387, ECO:0000269|PubMed:16289642, ECO:0000269|PubMed:16357216, ECO:0000269|PubMed:16424907, ECO:0000269|PubMed:17452327, ECO:0000269|PubMed:18178619}. |
Q9Y2W1 | THRAP3 | S560 | ochoa | Thyroid hormone receptor-associated protein 3 (BCLAF1 and THRAP3 family member 2) (Thyroid hormone receptor-associated protein complex 150 kDa component) (Trap150) | Involved in pre-mRNA splicing. Remains associated with spliced mRNA after splicing which probably involves interactions with the exon junction complex (EJC). Can trigger mRNA decay which seems to be independent of nonsense-mediated decay involving premature stop codons (PTC) recognition. May be involved in nuclear mRNA decay. Involved in regulation of signal-induced alternative splicing. During splicing of PTPRC/CD45 is proposed to sequester phosphorylated SFPQ from PTPRC/CD45 pre-mRNA in resting T-cells. Involved in cyclin-D1/CCND1 mRNA stability probably by acting as component of the SNARP complex which associates with both the 3'end of the CCND1 gene and its mRNA. Involved in response to DNA damage. Is excluced from DNA damage sites in a manner that parallels transcription inhibition; the function may involve the SNARP complex. Initially thought to play a role in transcriptional coactivation through its association with the TRAP complex; however, it is not regarded as a stable Mediator complex subunit. Cooperatively with HELZ2, enhances the transcriptional activation mediated by PPARG, maybe through the stabilization of the PPARG binding to DNA in presence of ligand. May play a role in the terminal stage of adipocyte differentiation. Plays a role in the positive regulation of the circadian clock. Acts as a coactivator of the CLOCK-BMAL1 heterodimer and promotes its transcriptional activator activity and binding to circadian target genes (PubMed:24043798). {ECO:0000269|PubMed:20123736, ECO:0000269|PubMed:20932480, ECO:0000269|PubMed:22424773, ECO:0000269|PubMed:23525231, ECO:0000269|PubMed:24043798}. |
Q9Y3B9 | RRP15 | S227 | ochoa | RRP15-like protein (Ribosomal RNA-processing protein 15) | None |
Q9Y3Z3 | SAMHD1 | S519 | ochoa | Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 (dNTPase) (EC 3.1.5.-) (Dendritic cell-derived IFNG-induced protein) (DCIP) (Monocyte protein 5) (MOP-5) (SAM domain and HD domain-containing protein 1) (hSAMHD1) | Protein that acts both as a host restriction factor involved in defense response to virus and as a regulator of DNA end resection at stalled replication forks (PubMed:19525956, PubMed:21613998, PubMed:21720370, PubMed:22056990, PubMed:23601106, PubMed:23602554, PubMed:24336198, PubMed:26294762, PubMed:26431200, PubMed:28229507, PubMed:28834754, PubMed:29670289). Has deoxynucleoside triphosphate (dNTPase) activity, which is required to restrict infection by viruses, such as HIV-1: dNTPase activity reduces cellular dNTP levels to levels too low for retroviral reverse transcription to occur, blocking early-stage virus replication in dendritic and other myeloid cells (PubMed:19525956, PubMed:21613998, PubMed:21720370, PubMed:22056990, PubMed:23364794, PubMed:23601106, PubMed:23602554, PubMed:24336198, PubMed:25038827, PubMed:26101257, PubMed:26294762, PubMed:26431200, PubMed:28229507). Likewise, suppresses LINE-1 retrotransposon activity (PubMed:24035396, PubMed:24217394, PubMed:29610582). Not able to restrict infection by HIV-2 virus; because restriction activity is counteracted by HIV-2 viral protein Vpx (PubMed:21613998, PubMed:21720370). In addition to virus restriction, dNTPase activity acts as a regulator of DNA precursor pools by regulating dNTP pools (PubMed:23858451). Phosphorylation at Thr-592 acts as a switch to control dNTPase-dependent and -independent functions: it inhibits dNTPase activity and ability to restrict infection by viruses, while it promotes DNA end resection at stalled replication forks (PubMed:23601106, PubMed:23602554, PubMed:29610582, PubMed:29670289). Functions during S phase at stalled DNA replication forks to promote the resection of gapped or reversed forks: acts by stimulating the exonuclease activity of MRE11, activating the ATR-CHK1 pathway and allowing the forks to restart replication (PubMed:29670289). Its ability to promote degradation of nascent DNA at stalled replication forks is required to prevent induction of type I interferons, thereby preventing chronic inflammation (PubMed:27477283, PubMed:29670289). Ability to promote DNA end resection at stalled replication forks is independent of dNTPase activity (PubMed:29670289). Enhances immunoglobulin hypermutation in B-lymphocytes by promoting transversion mutation (By similarity). {ECO:0000250|UniProtKB:Q60710, ECO:0000269|PubMed:19525956, ECO:0000269|PubMed:21613998, ECO:0000269|PubMed:21720370, ECO:0000269|PubMed:22056990, ECO:0000269|PubMed:23364794, ECO:0000269|PubMed:23601106, ECO:0000269|PubMed:23602554, ECO:0000269|PubMed:23858451, ECO:0000269|PubMed:24035396, ECO:0000269|PubMed:24217394, ECO:0000269|PubMed:24336198, ECO:0000269|PubMed:25038827, ECO:0000269|PubMed:26101257, ECO:0000269|PubMed:26294762, ECO:0000269|PubMed:26431200, ECO:0000269|PubMed:27477283, ECO:0000269|PubMed:28229507, ECO:0000269|PubMed:28834754, ECO:0000269|PubMed:29610582, ECO:0000269|PubMed:29670289}. |
Q9Y5P4 | CERT1 | S150 | ochoa | Ceramide transfer protein (hCERT) (Collagen type IV alpha-3-binding protein) (Goodpasture antigen-binding protein) (GPBP) (START domain-containing protein 11) (StARD11) (StAR-related lipid transfer protein 11) | Shelters ceramides and diacylglycerol lipids inside its START domain and mediates the intracellular trafficking of ceramides and diacylglycerol lipids in a non-vesicular manner. {ECO:0000269|PubMed:14685229, ECO:0000269|PubMed:17591919, ECO:0000269|PubMed:18184806, ECO:0000269|PubMed:20036255}. |
Q9Y5X1 | SNX9 | S198 | ochoa | Sorting nexin-9 (SH3 and PX domain-containing protein 1) (Protein SDP1) (SH3 and PX domain-containing protein 3A) | Involved in endocytosis and intracellular vesicle trafficking, both during interphase and at the end of mitosis. Required for efficient progress through mitosis and cytokinesis. Required for normal formation of the cleavage furrow at the end of mitosis. Plays a role in endocytosis via clathrin-coated pits, but also clathrin-independent, actin-dependent fluid-phase endocytosis. Plays a role in macropinocytosis. Promotes internalization of TNFR. Promotes degradation of EGFR after EGF signaling. Stimulates the GTPase activity of DNM1. Promotes DNM1 oligomerization. Promotes activation of the Arp2/3 complex by WASL, and thereby plays a role in the reorganization of the F-actin cytoskeleton. Binds to membranes enriched in phosphatidylinositol 4,5-bisphosphate and promotes membrane tubulation. Has lower affinity for membranes enriched in phosphatidylinositol 3-phosphate. {ECO:0000269|PubMed:11799118, ECO:0000269|PubMed:12952949, ECO:0000269|PubMed:15703209, ECO:0000269|PubMed:17609109, ECO:0000269|PubMed:17948057, ECO:0000269|PubMed:18388313, ECO:0000269|PubMed:20427313, ECO:0000269|PubMed:21048941, ECO:0000269|PubMed:22718350}. |
Q9Y623 | MYH4 | S647 | ochoa | Myosin-4 (Myosin heavy chain 2b) (MyHC-2b) (Myosin heavy chain 4) (Myosin heavy chain IIb) (MyHC-IIb) (Myosin heavy chain, skeletal muscle, fetal) | Muscle contraction. |
Q9Y6A5 | TACC3 | S583 | ochoa | Transforming acidic coiled-coil-containing protein 3 (ERIC-1) | Plays a role in the microtubule-dependent coupling of the nucleus and the centrosome. Involved in the processes that regulate centrosome-mediated interkinetic nuclear migration (INM) of neural progenitors (By similarity). Acts as a component of the TACC3/ch-TOG/clathrin complex proposed to contribute to stabilization of kinetochore fibers of the mitotic spindle by acting as inter-microtubule bridge. The TACC3/ch-TOG/clathrin complex is required for the maintenance of kinetochore fiber tension (PubMed:21297582, PubMed:23532825). May be involved in the control of cell growth and differentiation. May contribute to cancer (PubMed:14767476). {ECO:0000250|UniProtKB:Q9JJ11, ECO:0000269|PubMed:14767476, ECO:0000269|PubMed:21297582, ECO:0000269|PubMed:23532825}. |
R4GMW8 | BIVM-ERCC5 | S1523 | ochoa | DNA excision repair protein ERCC-5 | None |
P12277 | CKB | S129 | Sugiyama | Creatine kinase B-type (EC 2.7.3.2) (Brain creatine kinase) (B-CK) (Creatine kinase B chain) (Creatine phosphokinase B-type) (CPK-B) | Reversibly catalyzes the transfer of phosphate between ATP and various phosphogens (e.g. creatine phosphate) (PubMed:8186255). Creatine kinase isoenzymes play a central role in energy transduction in tissues with large, fluctuating energy demands, such as skeletal muscle, heart, brain and spermatozoa (Probable). Acts as a key regulator of adaptive thermogenesis as part of the futile creatine cycle: localizes to the mitochondria of thermogenic fat cells and acts by mediating phosphorylation of creatine to initiate a futile cycle of creatine phosphorylation and dephosphorylation (By similarity). During the futile creatine cycle, creatine and N-phosphocreatine are in a futile cycle, which dissipates the high energy charge of N-phosphocreatine as heat without performing any mechanical or chemical work (By similarity). {ECO:0000250|UniProtKB:Q04447, ECO:0000269|PubMed:8186255, ECO:0000305}. |
P68431 | H3C1 | Y42 | EPSD | Histone H3.1 (Histone H3/a) (Histone H3/b) (Histone H3/c) (Histone H3/d) (Histone H3/f) (Histone H3/h) (Histone H3/i) (Histone H3/j) (Histone H3/k) (Histone H3/l) | Core component of nucleosome. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling. |
Q08881 | ITK | Y225 | Sugiyama | Tyrosine-protein kinase ITK/TSK (EC 2.7.10.2) (Interleukin-2-inducible T-cell kinase) (IL-2-inducible T-cell kinase) (Kinase EMT) (T-cell-specific kinase) (Tyrosine-protein kinase Lyk) | Tyrosine kinase that plays an essential role in regulation of the adaptive immune response. Regulates the development, function and differentiation of conventional T-cells and nonconventional NKT-cells. When antigen presenting cells (APC) activate T-cell receptor (TCR), a series of phosphorylation lead to the recruitment of ITK to the cell membrane, in the vicinity of the stimulated TCR receptor, where it is phosphorylated by LCK. Phosphorylation leads to ITK autophosphorylation and full activation. Once activated, phosphorylates PLCG1, leading to the activation of this lipase and subsequent cleavage of its substrates. In turn, the endoplasmic reticulum releases calcium in the cytoplasm and the nuclear activator of activated T-cells (NFAT) translocates into the nucleus to perform its transcriptional duty. Phosphorylates 2 essential adapter proteins: the linker for activation of T-cells/LAT protein and LCP2. Then, a large number of signaling molecules such as VAV1 are recruited and ultimately lead to lymphokine production, T-cell proliferation and differentiation (PubMed:12186560, PubMed:12682224, PubMed:21725281). Required for TCR-mediated calcium response in gamma-delta T-cells, may also be involved in the modulation of the transcriptomic signature in the Vgamma2-positive subset of immature gamma-delta T-cells (By similarity). Phosphorylates TBX21 at 'Tyr-530' and mediates its interaction with GATA3 (By similarity). {ECO:0000250|UniProtKB:Q03526, ECO:0000269|PubMed:12186560, ECO:0000269|PubMed:12682224, ECO:0000269|PubMed:21725281}. |
Q16531 | DDB1 | S379 | Sugiyama | DNA damage-binding protein 1 (DDB p127 subunit) (DNA damage-binding protein a) (DDBa) (Damage-specific DNA-binding protein 1) (HBV X-associated protein 1) (XAP-1) (UV-damaged DNA-binding factor) (UV-damaged DNA-binding protein 1) (UV-DDB 1) (XPE-binding factor) (XPE-BF) (Xeroderma pigmentosum group E-complementing protein) (XPCe) | Protein, which is both involved in DNA repair and protein ubiquitination, as part of the UV-DDB complex and DCX (DDB1-CUL4-X-box) complexes, respectively (PubMed:14739464, PubMed:15448697, PubMed:16260596, PubMed:16407242, PubMed:16407252, PubMed:16482215, PubMed:16940174, PubMed:17079684). Core component of the UV-DDB complex (UV-damaged DNA-binding protein complex), a complex that recognizes UV-induced DNA damage and recruit proteins of the nucleotide excision repair pathway (the NER pathway) to initiate DNA repair (PubMed:15448697, PubMed:16260596, PubMed:16407242, PubMed:16940174). The UV-DDB complex preferentially binds to cyclobutane pyrimidine dimers (CPD), 6-4 photoproducts (6-4 PP), apurinic sites and short mismatches (PubMed:15448697, PubMed:16260596, PubMed:16407242, PubMed:16940174). Also functions as a component of numerous distinct DCX (DDB1-CUL4-X-box) E3 ubiquitin-protein ligase complexes which mediate the ubiquitination and subsequent proteasomal degradation of target proteins (PubMed:14739464, PubMed:16407252, PubMed:16482215, PubMed:17079684, PubMed:18332868, PubMed:18381890, PubMed:19966799, PubMed:22118460, PubMed:25043012, PubMed:25108355, PubMed:28886238). The functional specificity of the DCX E3 ubiquitin-protein ligase complex is determined by the variable substrate recognition component recruited by DDB1 (PubMed:14739464, PubMed:16407252, PubMed:16482215, PubMed:17079684, PubMed:18332868, PubMed:18381890, PubMed:19966799, PubMed:22118460, PubMed:25043012, PubMed:25108355). DCX(DDB2) (also known as DDB1-CUL4-ROC1, CUL4-DDB-ROC1 and CUL4-DDB-RBX1) may ubiquitinate histone H2A, histone H3 and histone H4 at sites of UV-induced DNA damage (PubMed:16473935, PubMed:16678110, PubMed:17041588, PubMed:18593899). The ubiquitination of histones may facilitate their removal from the nucleosome and promote subsequent DNA repair (PubMed:16473935, PubMed:16678110, PubMed:17041588, PubMed:18593899). DCX(DDB2) also ubiquitinates XPC, which may enhance DNA-binding by XPC and promote NER (PubMed:15882621). DCX(DTL) plays a role in PCNA-dependent polyubiquitination of CDT1 and MDM2-dependent ubiquitination of TP53 in response to radiation-induced DNA damage and during DNA replication (PubMed:17041588). DCX(ERCC8) (the CSA complex) plays a role in transcription-coupled repair (TCR) (PubMed:12732143, PubMed:32355176, PubMed:38316879). The DDB1-CUL4A-DTL E3 ligase complex regulates the circadian clock function by mediating the ubiquitination and degradation of CRY1 (PubMed:26431207). DDB1-mediated CRY1 degradation promotes FOXO1 protein stability and FOXO1-mediated gluconeogenesis in the liver (By similarity). By acting on TET dioxygenses, essential for oocyte maintenance at the primordial follicle stage, hence essential for female fertility (By similarity). Maternal factor required for proper zygotic genome activation and genome reprogramming (By similarity). {ECO:0000250|UniProtKB:Q3U1J4, ECO:0000269|PubMed:12732143, ECO:0000269|PubMed:14739464, ECO:0000269|PubMed:15448697, ECO:0000269|PubMed:15882621, ECO:0000269|PubMed:16260596, ECO:0000269|PubMed:16407242, ECO:0000269|PubMed:16407252, ECO:0000269|PubMed:16473935, ECO:0000269|PubMed:16482215, ECO:0000269|PubMed:16678110, ECO:0000269|PubMed:16940174, ECO:0000269|PubMed:17041588, ECO:0000269|PubMed:17079684, ECO:0000269|PubMed:18332868, ECO:0000269|PubMed:18381890, ECO:0000269|PubMed:18593899, ECO:0000269|PubMed:19966799, ECO:0000269|PubMed:22118460, ECO:0000269|PubMed:25043012, ECO:0000269|PubMed:25108355, ECO:0000269|PubMed:26431207, ECO:0000269|PubMed:28886238, ECO:0000269|PubMed:32355176, ECO:0000269|PubMed:38316879}. |
Q01844 | EWSR1 | S443 | Sugiyama | RNA-binding protein EWS (EWS oncogene) (Ewing sarcoma breakpoint region 1 protein) | Binds to ssRNA containing the consensus sequence 5'-AGGUAA-3' (PubMed:21256132). Might normally function as a transcriptional repressor (PubMed:10767297). EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. {ECO:0000269|PubMed:10767297, ECO:0000269|PubMed:21256132}. |
P84243 | H3-3A | Y42 | Sugiyama | Histone H3.3 | Variant histone H3 which replaces conventional H3 in a wide range of nucleosomes in active genes. Constitutes the predominant form of histone H3 in non-dividing cells and is incorporated into chromatin independently of DNA synthesis. Deposited at sites of nucleosomal displacement throughout transcribed genes, suggesting that it represents an epigenetic imprint of transcriptionally active chromatin. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling. {ECO:0000269|PubMed:14718166, ECO:0000269|PubMed:15776021, ECO:0000269|PubMed:16258499}. |
Q16695 | H3-4 | Y42 | Sugiyama | Histone H3.1t (H3/t) (H3t) (H3/g) (Histone H3.4) | Core component of nucleosome. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling. |
Q71DI3 | H3C15 | Y42 | Sugiyama | Histone H3.2 (H3-clustered histone 13) (H3-clustered histone 14) (H3-clustered histone 15) (Histone H3/m) (Histone H3/o) | Core component of nucleosome. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling. |
Download
reactome_id | name | p | -log10_p |
---|---|---|---|
R-HSA-190840 | Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | 1.001916e-09 | 8.999 |
R-HSA-190872 | Transport of connexons to the plasma membrane | 1.358232e-09 | 8.867 |
R-HSA-6811436 | COPI-independent Golgi-to-ER retrograde traffic | 4.034668e-09 | 8.394 |
R-HSA-9646399 | Aggrephagy | 7.915844e-09 | 8.102 |
R-HSA-68886 | M Phase | 8.513030e-09 | 8.070 |
R-HSA-380320 | Recruitment of NuMA to mitotic centrosomes | 1.163231e-08 | 7.934 |
R-HSA-9619483 | Activation of AMPK downstream of NMDARs | 1.942306e-08 | 7.712 |
R-HSA-3371497 | HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of lig... | 1.993744e-08 | 7.700 |
R-HSA-8866904 | Negative regulation of activity of TFAP2 (AP-2) family transcription factors | 4.614512e-08 | 7.336 |
R-HSA-9668328 | Sealing of the nuclear envelope (NE) by ESCRT-III | 4.903021e-08 | 7.310 |
R-HSA-190861 | Gap junction assembly | 6.863067e-08 | 7.163 |
R-HSA-389977 | Post-chaperonin tubulin folding pathway | 8.478322e-08 | 7.072 |
R-HSA-389957 | Prefoldin mediated transfer of substrate to CCT/TriC | 2.010254e-07 | 6.697 |
R-HSA-9609736 | Assembly and cell surface presentation of NMDA receptors | 2.261987e-07 | 6.646 |
R-HSA-389960 | Formation of tubulin folding intermediates by CCT/TriC | 2.447031e-07 | 6.611 |
R-HSA-68877 | Mitotic Prometaphase | 2.588244e-07 | 6.587 |
R-HSA-6807878 | COPI-mediated anterograde transport | 3.490618e-07 | 6.457 |
R-HSA-190828 | Gap junction trafficking | 3.358741e-07 | 6.474 |
R-HSA-5620920 | Cargo trafficking to the periciliary membrane | 4.039095e-07 | 6.394 |
R-HSA-8955332 | Carboxyterminal post-translational modifications of tubulin | 4.872244e-07 | 6.312 |
R-HSA-437239 | Recycling pathway of L1 | 4.872244e-07 | 6.312 |
R-HSA-1445148 | Translocation of SLC2A4 (GLUT4) to the plasma membrane | 4.865457e-07 | 6.313 |
R-HSA-157858 | Gap junction trafficking and regulation | 6.170778e-07 | 6.210 |
R-HSA-389958 | Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | 8.212450e-07 | 6.086 |
R-HSA-9648025 | EML4 and NUDC in mitotic spindle formation | 9.574883e-07 | 6.019 |
R-HSA-5617833 | Cilium Assembly | 1.673810e-06 | 5.776 |
R-HSA-9663891 | Selective autophagy | 1.841808e-06 | 5.735 |
R-HSA-983189 | Kinesins | 1.967585e-06 | 5.706 |
R-HSA-9609690 | HCMV Early Events | 2.191125e-06 | 5.659 |
R-HSA-69278 | Cell Cycle, Mitotic | 2.064979e-06 | 5.685 |
R-HSA-2500257 | Resolution of Sister Chromatid Cohesion | 2.326491e-06 | 5.633 |
R-HSA-8852276 | The role of GTSE1 in G2/M progression after G2 checkpoint | 2.377323e-06 | 5.624 |
R-HSA-2132295 | MHC class II antigen presentation | 2.618975e-06 | 5.582 |
R-HSA-8866907 | Activation of the TFAP2 (AP-2) family of transcription factors | 3.665002e-06 | 5.436 |
R-HSA-2467813 | Separation of Sister Chromatids | 3.471244e-06 | 5.460 |
R-HSA-8856688 | Golgi-to-ER retrograde transport | 4.861004e-06 | 5.313 |
R-HSA-983231 | Factors involved in megakaryocyte development and platelet production | 6.044552e-06 | 5.219 |
R-HSA-1632852 | Macroautophagy | 8.166630e-06 | 5.088 |
R-HSA-5620924 | Intraflagellar transport | 8.677861e-06 | 5.062 |
R-HSA-69275 | G2/M Transition | 9.716342e-06 | 5.012 |
R-HSA-1640170 | Cell Cycle | 1.071978e-05 | 4.970 |
R-HSA-453274 | Mitotic G2-G2/M phases | 1.055842e-05 | 4.976 |
R-HSA-2995410 | Nuclear Envelope (NE) Reassembly | 1.042541e-05 | 4.982 |
R-HSA-9833482 | PKR-mediated signaling | 1.042541e-05 | 4.982 |
R-HSA-199977 | ER to Golgi Anterograde Transport | 1.149002e-05 | 4.940 |
R-HSA-9609646 | HCMV Infection | 1.826249e-05 | 4.738 |
R-HSA-9612973 | Autophagy | 1.740624e-05 | 4.759 |
R-HSA-438064 | Post NMDA receptor activation events | 1.814569e-05 | 4.741 |
R-HSA-68882 | Mitotic Anaphase | 3.199207e-05 | 4.495 |
R-HSA-2555396 | Mitotic Metaphase and Anaphase | 3.314158e-05 | 4.480 |
R-HSA-6811434 | COPI-dependent Golgi-to-ER retrograde traffic | 3.595870e-05 | 4.444 |
R-HSA-9834899 | Specification of the neural plate border | 5.428378e-05 | 4.265 |
R-HSA-442755 | Activation of NMDA receptors and postsynaptic events | 5.056034e-05 | 4.296 |
R-HSA-8864260 | Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | 8.295553e-05 | 4.081 |
R-HSA-9938206 | Developmental Lineage of Mammary Stem Cells | 9.801733e-05 | 4.009 |
R-HSA-6811442 | Intra-Golgi and retrograde Golgi-to-ER traffic | 1.008934e-04 | 3.996 |
R-HSA-1169410 | Antiviral mechanism by IFN-stimulated genes | 1.071424e-04 | 3.970 |
R-HSA-948021 | Transport to the Golgi and subsequent modification | 1.079845e-04 | 3.967 |
R-HSA-373760 | L1CAM interactions | 1.200367e-04 | 3.921 |
R-HSA-1852241 | Organelle biogenesis and maintenance | 1.412697e-04 | 3.850 |
R-HSA-199991 | Membrane Trafficking | 1.516506e-04 | 3.819 |
R-HSA-390466 | Chaperonin-mediated protein folding | 1.680425e-04 | 3.775 |
R-HSA-391251 | Protein folding | 2.321734e-04 | 3.634 |
R-HSA-380284 | Loss of proteins required for interphase microtubule organization from the centr... | 3.471627e-04 | 3.459 |
R-HSA-380259 | Loss of Nlp from mitotic centrosomes | 3.471627e-04 | 3.459 |
R-HSA-5610787 | Hedgehog 'off' state | 3.629119e-04 | 3.440 |
R-HSA-390522 | Striated Muscle Contraction | 3.780157e-04 | 3.422 |
R-HSA-8854518 | AURKA Activation by TPX2 | 4.185969e-04 | 3.378 |
R-HSA-380270 | Recruitment of mitotic centrosome proteins and complexes | 6.280629e-04 | 3.202 |
R-HSA-380287 | Centrosome maturation | 7.002313e-04 | 3.155 |
R-HSA-8866910 | TFAP2 (AP-2) family regulates transcription of growth factors and their receptor... | 7.653895e-04 | 3.116 |
R-HSA-8866906 | TFAP2 (AP-2) family regulates transcription of other transcription factors | 8.359977e-04 | 3.078 |
R-HSA-2565942 | Regulation of PLK1 Activity at G2/M Transition | 1.104186e-03 | 2.957 |
R-HSA-2299718 | Condensation of Prophase Chromosomes | 1.148147e-03 | 2.940 |
R-HSA-8866911 | TFAP2 (AP-2) family regulates transcription of cell cycle factors | 1.197299e-03 | 2.922 |
R-HSA-1474165 | Reproduction | 1.485180e-03 | 2.828 |
R-HSA-5620912 | Anchoring of the basal body to the plasma membrane | 1.521529e-03 | 2.818 |
R-HSA-5653656 | Vesicle-mediated transport | 1.523105e-03 | 2.817 |
R-HSA-912446 | Meiotic recombination | 1.584851e-03 | 2.800 |
R-HSA-5358351 | Signaling by Hedgehog | 2.001899e-03 | 2.699 |
R-HSA-427975 | Proton/oligopeptide cotransporters | 2.105497e-03 | 2.677 |
R-HSA-913531 | Interferon Signaling | 2.144804e-03 | 2.669 |
R-HSA-201722 | Formation of the beta-catenin:TCF transactivating complex | 2.373593e-03 | 2.625 |
R-HSA-2262752 | Cellular responses to stress | 2.531860e-03 | 2.597 |
R-HSA-73728 | RNA Polymerase I Promoter Opening | 2.762379e-03 | 2.559 |
R-HSA-422475 | Axon guidance | 2.841333e-03 | 2.546 |
R-HSA-597592 | Post-translational protein modification | 2.949587e-03 | 2.530 |
R-HSA-9959399 | SLC-mediated transport of oligopeptides | 3.254283e-03 | 2.488 |
R-HSA-5334118 | DNA methylation | 3.256210e-03 | 2.487 |
R-HSA-9917777 | Epigenetic regulation by WDR5-containing histone modifying complexes | 3.335778e-03 | 2.477 |
R-HSA-211000 | Gene Silencing by RNA | 3.348365e-03 | 2.475 |
R-HSA-112314 | Neurotransmitter receptors and postsynaptic signal transmission | 3.454001e-03 | 2.462 |
R-HSA-204626 | Hypusine synthesis from eIF5A-lysine | 4.635586e-03 | 2.334 |
R-HSA-5578749 | Transcriptional regulation by small RNAs | 4.688055e-03 | 2.329 |
R-HSA-68616 | Assembly of the ORC complex at the origin of replication | 4.397924e-03 | 2.357 |
R-HSA-9924644 | Developmental Lineages of the Mammary Gland | 4.688055e-03 | 2.329 |
R-HSA-9764560 | Regulation of CDH1 Gene Transcription | 4.290587e-03 | 2.367 |
R-HSA-9675108 | Nervous system development | 4.690380e-03 | 2.329 |
R-HSA-9843970 | Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | 5.048755e-03 | 2.297 |
R-HSA-68875 | Mitotic Prophase | 5.495424e-03 | 2.260 |
R-HSA-9764274 | Regulation of Expression and Function of Type I Classical Cadherins | 5.647135e-03 | 2.248 |
R-HSA-9764265 | Regulation of CDH1 Expression and Function | 5.647135e-03 | 2.248 |
R-HSA-212300 | PRC2 methylates histones and DNA | 5.754679e-03 | 2.240 |
R-HSA-9816359 | Maternal to zygotic transition (MZT) | 6.019634e-03 | 2.220 |
R-HSA-427359 | SIRT1 negatively regulates rRNA expression | 6.128677e-03 | 2.213 |
R-HSA-977225 | Amyloid fiber formation | 6.783495e-03 | 2.169 |
R-HSA-2559582 | Senescence-Associated Secretory Phenotype (SASP) | 7.048851e-03 | 2.152 |
R-HSA-5696395 | Formation of Incision Complex in GG-NER | 7.336476e-03 | 2.135 |
R-HSA-427389 | ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | 7.336476e-03 | 2.135 |
R-HSA-1280218 | Adaptive Immune System | 7.595992e-03 | 2.119 |
R-HSA-5696399 | Global Genome Nucleotide Excision Repair (GG-NER) | 7.599961e-03 | 2.119 |
R-HSA-9821002 | Chromatin modifications during the maternal to zygotic transition (MZT) | 7.768098e-03 | 2.110 |
R-HSA-5625886 | Activated PKN1 stimulates transcription of AR (androgen receptor) regulated gene... | 7.768098e-03 | 2.110 |
R-HSA-1500620 | Meiosis | 7.885856e-03 | 2.103 |
R-HSA-8953897 | Cellular responses to stimuli | 8.254887e-03 | 2.083 |
R-HSA-9710421 | Defective pyroptosis | 9.151643e-03 | 2.039 |
R-HSA-9759476 | Regulation of Homotypic Cell-Cell Adhesion | 9.553069e-03 | 2.020 |
R-HSA-73772 | RNA Polymerase I Promoter Escape | 1.412183e-02 | 1.850 |
R-HSA-5693571 | Nonhomologous End-Joining (NHEJ) | 1.175897e-02 | 1.930 |
R-HSA-8875360 | InlB-mediated entry of Listeria monocytogenes into host cell | 1.118927e-02 | 1.951 |
R-HSA-68867 | Assembly of the pre-replicative complex | 1.113977e-02 | 1.953 |
R-HSA-69306 | DNA Replication | 1.461642e-02 | 1.835 |
R-HSA-446203 | Asparagine N-linked glycosylation | 1.216640e-02 | 1.915 |
R-HSA-5250924 | B-WICH complex positively regulates rRNA expression | 1.475154e-02 | 1.831 |
R-HSA-9827857 | Specification of primordial germ cells | 1.476094e-02 | 1.831 |
R-HSA-9824446 | Viral Infection Pathways | 1.490080e-02 | 1.827 |
R-HSA-418990 | Adherens junctions interactions | 1.508992e-02 | 1.821 |
R-HSA-162582 | Signal Transduction | 1.547494e-02 | 1.810 |
R-HSA-392499 | Metabolism of proteins | 1.588046e-02 | 1.799 |
R-HSA-5696398 | Nucleotide Excision Repair | 1.698439e-02 | 1.770 |
R-HSA-9734779 | Developmental Cell Lineages of the Integumentary System | 1.844423e-02 | 1.734 |
R-HSA-6807004 | Negative regulation of MET activity | 1.875586e-02 | 1.727 |
R-HSA-69002 | DNA Replication Pre-Initiation | 1.894764e-02 | 1.722 |
R-HSA-9845323 | Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | 1.960101e-02 | 1.708 |
R-HSA-9764725 | Negative Regulation of CDH1 Gene Transcription | 1.960101e-02 | 1.708 |
R-HSA-9824594 | Regulation of MITF-M-dependent genes involved in apoptosis | 2.017760e-02 | 1.695 |
R-HSA-1266738 | Developmental Biology | 2.034706e-02 | 1.691 |
R-HSA-9616222 | Transcriptional regulation of granulopoiesis | 2.112930e-02 | 1.675 |
R-HSA-8876384 | Listeria monocytogenes entry into host cells | 2.164301e-02 | 1.665 |
R-HSA-9909649 | Regulation of PD-L1(CD274) transcription | 2.437684e-02 | 1.613 |
R-HSA-112315 | Transmission across Chemical Synapses | 2.523609e-02 | 1.598 |
R-HSA-2559583 | Cellular Senescence | 2.602970e-02 | 1.585 |
R-HSA-8936459 | RUNX1 regulates genes involved in megakaryocyte differentiation and platelet fun... | 2.609607e-02 | 1.583 |
R-HSA-421270 | Cell-cell junction organization | 2.644486e-02 | 1.578 |
R-HSA-9843940 | Regulation of endogenous retroelements by KRAB-ZFP proteins | 2.787883e-02 | 1.555 |
R-HSA-3214842 | HDMs demethylate histones | 2.792537e-02 | 1.554 |
R-HSA-1266695 | Interleukin-7 signaling | 2.792537e-02 | 1.554 |
R-HSA-5250913 | Positive epigenetic regulation of rRNA expression | 2.879399e-02 | 1.541 |
R-HSA-427413 | NoRC negatively regulates rRNA expression | 2.879399e-02 | 1.541 |
R-HSA-9851695 | Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | 3.015461e-02 | 1.521 |
R-HSA-9841922 | MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesi... | 3.015461e-02 | 1.521 |
R-HSA-9818564 | Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | 3.015461e-02 | 1.521 |
R-HSA-5696394 | DNA Damage Recognition in GG-NER | 4.431289e-02 | 1.353 |
R-HSA-5696400 | Dual Incision in GG-NER | 4.630920e-02 | 1.334 |
R-HSA-6781827 | Transcription-Coupled Nucleotide Excision Repair (TC-NER) | 3.261257e-02 | 1.487 |
R-HSA-8856828 | Clathrin-mediated endocytosis | 4.628907e-02 | 1.335 |
R-HSA-9708296 | tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis | 3.274185e-02 | 1.485 |
R-HSA-165181 | Inhibition of TSC complex formation by PKB | 4.871149e-02 | 1.312 |
R-HSA-5250941 | Negative epigenetic regulation of rRNA expression | 3.773863e-02 | 1.423 |
R-HSA-182971 | EGFR downregulation | 3.852604e-02 | 1.414 |
R-HSA-73894 | DNA Repair | 4.037383e-02 | 1.394 |
R-HSA-73854 | RNA Polymerase I Promoter Clearance | 3.360655e-02 | 1.474 |
R-HSA-8939236 | RUNX1 regulates transcription of genes involved in differentiation of HSCs | 4.211833e-02 | 1.376 |
R-HSA-73864 | RNA Polymerase I Transcription | 3.564144e-02 | 1.448 |
R-HSA-9772755 | Formation of WDR5-containing histone-modifying complexes | 4.833807e-02 | 1.316 |
R-HSA-446728 | Cell junction organization | 3.914887e-02 | 1.407 |
R-HSA-9645723 | Diseases of programmed cell death | 4.793578e-02 | 1.319 |
R-HSA-1912408 | Pre-NOTCH Transcription and Translation | 5.160598e-02 | 1.287 |
R-HSA-9758941 | Gastrulation | 5.163172e-02 | 1.287 |
R-HSA-180910 | Vpr-mediated nuclear import of PICs | 5.249080e-02 | 1.280 |
R-HSA-112316 | Neuronal System | 5.253998e-02 | 1.280 |
R-HSA-5693532 | DNA Double-Strand Break Repair | 5.537353e-02 | 1.257 |
R-HSA-110381 | Resolution of AP sites via the single-nucleotide replacement pathway | 5.659790e-02 | 1.247 |
R-HSA-8866376 | Reelin signalling pathway | 5.659790e-02 | 1.247 |
R-HSA-9670095 | Inhibition of DNA recombination at telomere | 5.894760e-02 | 1.230 |
R-HSA-176033 | Interactions of Vpr with host cellular proteins | 5.894760e-02 | 1.230 |
R-HSA-3214841 | PKMTs methylate histone lysines | 6.115806e-02 | 1.214 |
R-HSA-9820841 | M-decay: degradation of maternal mRNAs by maternally stored factors | 6.115806e-02 | 1.214 |
R-HSA-1500931 | Cell-Cell communication | 6.274132e-02 | 1.202 |
R-HSA-9860276 | SLC15A4:TASL-dependent IRF5 activation | 6.441941e-02 | 1.191 |
R-HSA-3214847 | HATs acetylate histones | 6.478426e-02 | 1.189 |
R-HSA-69618 | Mitotic Spindle Checkpoint | 6.617985e-02 | 1.179 |
R-HSA-157118 | Signaling by NOTCH | 6.704482e-02 | 1.174 |
R-HSA-212165 | Epigenetic regulation of gene expression | 6.784025e-02 | 1.169 |
R-HSA-8854214 | TBC/RABGAPs | 6.795532e-02 | 1.168 |
R-HSA-9842860 | Regulation of endogenous retroelements | 6.901227e-02 | 1.161 |
R-HSA-2559580 | Oxidative Stress Induced Senescence | 6.901227e-02 | 1.161 |
R-HSA-3214858 | RMTs methylate histone arginines | 7.027437e-02 | 1.153 |
R-HSA-8869496 | TFAP2A acts as a transcriptional repressor during retinoic acid induced cell dif... | 7.217655e-02 | 1.142 |
R-HSA-177539 | Autointegration results in viral DNA circles | 7.217655e-02 | 1.142 |
R-HSA-426486 | Small interfering RNA (siRNA) biogenesis | 7.217655e-02 | 1.142 |
R-HSA-175567 | Integration of viral DNA into host genomic DNA | 7.217655e-02 | 1.142 |
R-HSA-109582 | Hemostasis | 7.330358e-02 | 1.135 |
R-HSA-5617472 | Activation of anterior HOX genes in hindbrain development during early embryogen... | 7.336261e-02 | 1.135 |
R-HSA-5619507 | Activation of HOX genes during differentiation | 7.336261e-02 | 1.135 |
R-HSA-139915 | Activation of PUMA and translocation to mitochondria | 7.986985e-02 | 1.098 |
R-HSA-428890 | Role of ABL in ROBO-SLIT signaling | 7.986985e-02 | 1.098 |
R-HSA-3371599 | Defective HLCS causes multiple carboxylase deficiency | 7.986985e-02 | 1.098 |
R-HSA-9766229 | Degradation of CDH1 | 8.224325e-02 | 1.085 |
R-HSA-69620 | Cell Cycle Checkpoints | 8.358102e-02 | 1.078 |
R-HSA-1912422 | Pre-NOTCH Expression and Processing | 8.712091e-02 | 1.060 |
R-HSA-201681 | TCF dependent signaling in response to WNT | 8.912603e-02 | 1.050 |
R-HSA-112382 | Formation of RNA Pol II elongation complex | 8.970336e-02 | 1.047 |
R-HSA-176412 | Phosphorylation of the APC/C | 1.534043e-01 | 0.814 |
R-HSA-5083625 | Defective GALNT3 causes HFTC | 1.534043e-01 | 0.814 |
R-HSA-5083636 | Defective GALNT12 causes CRCS1 | 1.534043e-01 | 0.814 |
R-HSA-9687136 | Aberrant regulation of mitotic exit in cancer due to RB1 defects | 1.534043e-01 | 0.814 |
R-HSA-5083632 | Defective C1GALT1C1 causes TNPS | 1.673956e-01 | 0.776 |
R-HSA-174048 | APC/C:Cdc20 mediated degradation of Cyclin B | 1.811573e-01 | 0.742 |
R-HSA-6782210 | Gap-filling DNA repair synthesis and ligation in TC-NER | 9.994549e-02 | 1.000 |
R-HSA-6782135 | Dual incision in TC-NER | 1.051840e-01 | 0.978 |
R-HSA-3214815 | HDACs deacetylate histones | 9.735486e-02 | 1.012 |
R-HSA-5693565 | Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at... | 1.078308e-01 | 0.967 |
R-HSA-162592 | Integration of provirus | 1.173969e-01 | 0.930 |
R-HSA-176407 | Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | 1.673956e-01 | 0.776 |
R-HSA-75955 | RNA Polymerase II Transcription Elongation | 9.223329e-02 | 1.035 |
R-HSA-5693606 | DNA Double Strand Break Response | 1.296069e-01 | 0.887 |
R-HSA-5649702 | APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement P... | 9.506702e-02 | 1.022 |
R-HSA-8951664 | Neddylation | 1.424987e-01 | 0.846 |
R-HSA-9603798 | Class I peroxisomal membrane protein import | 1.534043e-01 | 0.814 |
R-HSA-141430 | Inactivation of APC/C via direct inhibition of the APC/C complex | 1.604289e-01 | 0.795 |
R-HSA-674695 | RNA Polymerase II Pre-transcription Events | 1.494149e-01 | 0.826 |
R-HSA-426048 | Arachidonate production from DAG | 1.025719e-01 | 0.989 |
R-HSA-164843 | 2-LTR circle formation | 1.025719e-01 | 0.989 |
R-HSA-71032 | Propionyl-CoA catabolism | 1.100150e-01 | 0.959 |
R-HSA-416550 | Sema4D mediated inhibition of cell attachment and migration | 1.173969e-01 | 0.930 |
R-HSA-180689 | APOBEC3G mediated resistance to HIV-1 infection | 1.173969e-01 | 0.930 |
R-HSA-141405 | Inhibition of the proteolytic activity of APC/C required for the onset of anapha... | 1.604289e-01 | 0.795 |
R-HSA-6803211 | TP53 Regulates Transcription of Death Receptors and Ligands | 1.391797e-01 | 0.856 |
R-HSA-5685939 | HDR through MMEJ (alt-NHEJ) | 1.319787e-01 | 0.879 |
R-HSA-196780 | Biotin transport and metabolism | 1.463214e-01 | 0.835 |
R-HSA-162587 | HIV Life Cycle | 1.795144e-01 | 0.746 |
R-HSA-9018519 | Estrogen-dependent gene expression | 1.359648e-01 | 0.867 |
R-HSA-177929 | Signaling by EGFR | 9.994549e-02 | 1.000 |
R-HSA-3323169 | Defects in biotin (Btn) metabolism | 9.506702e-02 | 1.022 |
R-HSA-69473 | G2/M DNA damage checkpoint | 1.494149e-01 | 0.826 |
R-HSA-9610379 | HCMV Late Events | 1.795144e-01 | 0.746 |
R-HSA-9764790 | Positive Regulation of CDH1 Gene Transcription | 1.025719e-01 | 0.989 |
R-HSA-2028269 | Signaling by Hippo | 1.673956e-01 | 0.776 |
R-HSA-9764561 | Regulation of CDH1 Function | 1.025554e-01 | 0.989 |
R-HSA-5693607 | Processing of DNA double-strand break ends | 1.697808e-01 | 0.770 |
R-HSA-6804759 | Regulation of TP53 Activity through Association with Co-factors | 1.319787e-01 | 0.879 |
R-HSA-9679191 | Potential therapeutics for SARS | 1.652521e-01 | 0.782 |
R-HSA-9012852 | Signaling by NOTCH3 | 9.735486e-02 | 1.012 |
R-HSA-397014 | Muscle contraction | 1.292133e-01 | 0.889 |
R-HSA-5693538 | Homology Directed Repair | 9.851836e-02 | 1.006 |
R-HSA-9913635 | Strand-asynchronous mitochondrial DNA replication | 1.811573e-01 | 0.742 |
R-HSA-5663205 | Infectious disease | 1.188789e-01 | 0.925 |
R-HSA-6806834 | Signaling by MET | 1.668421e-01 | 0.778 |
R-HSA-9856651 | MITF-M-dependent gene expression | 1.652521e-01 | 0.782 |
R-HSA-141424 | Amplification of signal from the kinetochores | 1.845996e-01 | 0.734 |
R-HSA-141444 | Amplification of signal from unattached kinetochores via a MAD2 inhibitory si... | 1.845996e-01 | 0.734 |
R-HSA-5633007 | Regulation of TP53 Activity | 1.857282e-01 | 0.731 |
R-HSA-163841 | Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | 1.875861e-01 | 0.727 |
R-HSA-5620916 | VxPx cargo-targeting to cilium | 1.879533e-01 | 0.726 |
R-HSA-71288 | Creatine metabolism | 1.879533e-01 | 0.726 |
R-HSA-179409 | APC-Cdc20 mediated degradation of Nek2A | 1.946933e-01 | 0.711 |
R-HSA-162594 | Early Phase of HIV Life Cycle | 1.946933e-01 | 0.711 |
R-HSA-73884 | Base Excision Repair | 1.995971e-01 | 0.700 |
R-HSA-1280215 | Cytokine Signaling in Immune system | 2.012531e-01 | 0.696 |
R-HSA-5696397 | Gap-filling DNA repair synthesis and ligation in GG-NER | 2.013777e-01 | 0.696 |
R-HSA-6803205 | TP53 regulates transcription of several additional cell death genes whose specif... | 2.080071e-01 | 0.682 |
R-HSA-9013507 | NOTCH3 Activation and Transmission of Signal to the Nucleus | 2.080071e-01 | 0.682 |
R-HSA-9734767 | Developmental Cell Lineages | 2.107256e-01 | 0.676 |
R-HSA-9909648 | Regulation of PD-L1(CD274) expression | 2.132670e-01 | 0.671 |
R-HSA-977068 | Termination of O-glycan biosynthesis | 2.145819e-01 | 0.668 |
R-HSA-74160 | Gene expression (Transcription) | 2.160764e-01 | 0.665 |
R-HSA-9821993 | Replacement of protamines by nucleosomes in the male pronucleus | 2.211024e-01 | 0.655 |
R-HSA-110314 | Recognition of DNA damage by PCNA-containing replication complex | 2.211024e-01 | 0.655 |
R-HSA-168256 | Immune System | 2.252540e-01 | 0.647 |
R-HSA-157579 | Telomere Maintenance | 2.269209e-01 | 0.644 |
R-HSA-203927 | MicroRNA (miRNA) biogenesis | 2.275693e-01 | 0.643 |
R-HSA-400685 | Sema4D in semaphorin signaling | 2.275693e-01 | 0.643 |
R-HSA-8957275 | Post-translational protein phosphorylation | 2.299758e-01 | 0.638 |
R-HSA-3295583 | TRP channels | 2.339828e-01 | 0.631 |
R-HSA-167243 | Tat-mediated HIV elongation arrest and recovery | 2.403435e-01 | 0.619 |
R-HSA-171306 | Packaging Of Telomere Ends | 2.403435e-01 | 0.619 |
R-HSA-167238 | Pausing and recovery of Tat-mediated HIV elongation | 2.403435e-01 | 0.619 |
R-HSA-6803204 | TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | 2.403435e-01 | 0.619 |
R-HSA-264876 | Insulin processing | 2.403435e-01 | 0.619 |
R-HSA-167287 | HIV elongation arrest and recovery | 2.466518e-01 | 0.608 |
R-HSA-167290 | Pausing and recovery of HIV elongation | 2.466518e-01 | 0.608 |
R-HSA-8856825 | Cargo recognition for clathrin-mediated endocytosis | 2.483558e-01 | 0.605 |
R-HSA-5619107 | Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC... | 2.591128e-01 | 0.587 |
R-HSA-9687139 | Aberrant regulation of mitotic cell cycle due to RB1 defects | 2.591128e-01 | 0.587 |
R-HSA-380972 | Energy dependent regulation of mTOR by LKB1-AMPK | 2.591128e-01 | 0.587 |
R-HSA-114452 | Activation of BH3-only proteins | 2.591128e-01 | 0.587 |
R-HSA-9013508 | NOTCH3 Intracellular Domain Regulates Transcription | 2.591128e-01 | 0.587 |
R-HSA-1855196 | IP3 and IP4 transport between cytosol and nucleus | 2.652663e-01 | 0.576 |
R-HSA-1855229 | IP6 and IP7 transport between cytosol and nucleus | 2.652663e-01 | 0.576 |
R-HSA-2129379 | Molecules associated with elastic fibres | 2.652663e-01 | 0.576 |
R-HSA-936440 | Negative regulators of DDX58/IFIH1 signaling | 2.652663e-01 | 0.576 |
R-HSA-110330 | Recognition and association of DNA glycosylase with site containing an affected ... | 2.713692e-01 | 0.566 |
R-HSA-9675126 | Diseases of mitotic cell cycle | 2.713692e-01 | 0.566 |
R-HSA-195721 | Signaling by WNT | 2.733028e-01 | 0.563 |
R-HSA-389948 | Co-inhibition by PD-1 | 2.750505e-01 | 0.561 |
R-HSA-1855170 | IPs transport between nucleus and cytosol | 2.774217e-01 | 0.557 |
R-HSA-159227 | Transport of the SLBP independent Mature mRNA | 2.774217e-01 | 0.557 |
R-HSA-6804758 | Regulation of TP53 Activity through Acetylation | 2.774217e-01 | 0.557 |
R-HSA-5693567 | HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | 2.821449e-01 | 0.550 |
R-HSA-159230 | Transport of the SLBP Dependant Mature mRNA | 2.834243e-01 | 0.548 |
R-HSA-170822 | Regulation of Glucokinase by Glucokinase Regulatory Protein | 2.834243e-01 | 0.548 |
R-HSA-114508 | Effects of PIP2 hydrolysis | 2.834243e-01 | 0.548 |
R-HSA-381426 | Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-l... | 2.852147e-01 | 0.545 |
R-HSA-5628897 | TP53 Regulates Metabolic Genes | 2.882833e-01 | 0.540 |
R-HSA-180746 | Nuclear import of Rev protein | 2.893774e-01 | 0.539 |
R-HSA-110328 | Recognition and association of DNA glycosylase with site containing an affected ... | 2.893774e-01 | 0.539 |
R-HSA-909733 | Interferon alpha/beta signaling | 2.913506e-01 | 0.536 |
R-HSA-3301854 | Nuclear Pore Complex (NPC) Disassembly | 2.952814e-01 | 0.530 |
R-HSA-3296482 | Defects in vitamin and cofactor metabolism | 2.952814e-01 | 0.530 |
R-HSA-9007101 | Rab regulation of trafficking | 2.974802e-01 | 0.527 |
R-HSA-9730414 | MITF-M-regulated melanocyte development | 3.066632e-01 | 0.513 |
R-HSA-110331 | Cleavage of the damaged purine | 3.069437e-01 | 0.513 |
R-HSA-73886 | Chromosome Maintenance | 3.097148e-01 | 0.509 |
R-HSA-73927 | Depurination | 3.127029e-01 | 0.505 |
R-HSA-165054 | Rev-mediated nuclear export of HIV RNA | 3.127029e-01 | 0.505 |
R-HSA-1566948 | Elastic fibre formation | 3.127029e-01 | 0.505 |
R-HSA-159231 | Transport of Mature mRNA Derived from an Intronless Transcript | 3.184145e-01 | 0.497 |
R-HSA-167200 | Formation of HIV-1 elongation complex containing HIV-1 Tat | 3.184145e-01 | 0.497 |
R-HSA-168276 | NS1 Mediated Effects on Host Pathways | 3.184145e-01 | 0.497 |
R-HSA-162909 | Host Interactions of HIV factors | 3.188638e-01 | 0.496 |
R-HSA-159234 | Transport of Mature mRNAs Derived from Intronless Transcripts | 3.240790e-01 | 0.489 |
R-HSA-167246 | Tat-mediated elongation of the HIV-1 transcript | 3.240790e-01 | 0.489 |
R-HSA-167152 | Formation of HIV elongation complex in the absence of HIV Tat | 3.240790e-01 | 0.489 |
R-HSA-167169 | HIV Transcription Elongation | 3.240790e-01 | 0.489 |
R-HSA-177243 | Interactions of Rev with host cellular proteins | 3.240790e-01 | 0.489 |
R-HSA-9604323 | Negative regulation of NOTCH4 signaling | 3.240790e-01 | 0.489 |
R-HSA-202433 | Generation of second messenger molecules | 3.240790e-01 | 0.489 |
R-HSA-168271 | Transport of Ribonucleoproteins into the Host Nucleus | 3.296968e-01 | 0.482 |
R-HSA-73933 | Resolution of Abasic Sites (AP sites) | 3.296968e-01 | 0.482 |
R-HSA-73817 | Purine ribonucleoside monophosphate biosynthesis | 3.296968e-01 | 0.482 |
R-HSA-8853884 | Transcriptional Regulation by VENTX | 3.296968e-01 | 0.482 |
R-HSA-69481 | G2/M Checkpoints | 3.310183e-01 | 0.480 |
R-HSA-8878171 | Transcriptional regulation by RUNX1 | 3.361554e-01 | 0.473 |
R-HSA-162906 | HIV Infection | 3.384242e-01 | 0.471 |
R-HSA-165159 | MTOR signalling | 3.407938e-01 | 0.468 |
R-HSA-110329 | Cleavage of the damaged pyrimidine | 3.407938e-01 | 0.468 |
R-HSA-73928 | Depyrimidination | 3.407938e-01 | 0.468 |
R-HSA-2173789 | TGF-beta receptor signaling activates SMADs | 3.462737e-01 | 0.461 |
R-HSA-3928662 | EPHB-mediated forward signaling | 3.517083e-01 | 0.454 |
R-HSA-3247509 | Chromatin modifying enzymes | 3.542907e-01 | 0.451 |
R-HSA-168333 | NEP/NS2 Interacts with the Cellular Export Machinery | 3.570982e-01 | 0.447 |
R-HSA-9824585 | Regulation of MITF-M-dependent genes involved in pigmentation | 3.570982e-01 | 0.447 |
R-HSA-8939211 | ESR-mediated signaling | 3.610788e-01 | 0.442 |
R-HSA-174084 | Autodegradation of Cdh1 by Cdh1:APC/C | 3.624435e-01 | 0.441 |
R-HSA-6781823 | Formation of TC-NER Pre-Incision Complex | 3.624435e-01 | 0.441 |
R-HSA-168274 | Export of Viral Ribonucleoproteins from Nucleus | 3.624435e-01 | 0.441 |
R-HSA-6798695 | Neutrophil degranulation | 3.667144e-01 | 0.436 |
R-HSA-174154 | APC/C:Cdc20 mediated degradation of Securin | 3.677447e-01 | 0.434 |
R-HSA-73893 | DNA Damage Bypass | 3.782163e-01 | 0.422 |
R-HSA-3700989 | Transcriptional Regulation by TP53 | 3.799188e-01 | 0.420 |
R-HSA-5658442 | Regulation of RAS by GAPs | 3.833874e-01 | 0.416 |
R-HSA-9748787 | Azathioprine ADME | 3.833874e-01 | 0.416 |
R-HSA-162599 | Late Phase of HIV Life Cycle | 3.848514e-01 | 0.415 |
R-HSA-4839726 | Chromatin organization | 3.881144e-01 | 0.411 |
R-HSA-1234176 | Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | 3.885157e-01 | 0.411 |
R-HSA-9864848 | Complex IV assembly | 3.885157e-01 | 0.411 |
R-HSA-174184 | Cdc20:Phospho-APC/C mediated degradation of Cyclin A | 3.936018e-01 | 0.405 |
R-HSA-6794361 | Neurexins and neuroligins | 3.936018e-01 | 0.405 |
R-HSA-9692916 | SARS-CoV-1 activates/modulates innate immune responses | 3.936018e-01 | 0.405 |
R-HSA-179419 | APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of th... | 3.986458e-01 | 0.399 |
R-HSA-174178 | APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins ... | 3.986458e-01 | 0.399 |
R-HSA-1221632 | Meiotic synapsis | 3.986458e-01 | 0.399 |
R-HSA-432722 | Golgi Associated Vesicle Biogenesis | 3.986458e-01 | 0.399 |
R-HSA-8956320 | Nucleotide biosynthesis | 3.986458e-01 | 0.399 |
R-HSA-69017 | CDK-mediated phosphorylation and removal of Cdc6 | 4.036482e-01 | 0.394 |
R-HSA-73929 | Base-Excision Repair, AP Site Formation | 4.036482e-01 | 0.394 |
R-HSA-388841 | Regulation of T cell activation by CD28 family | 4.037672e-01 | 0.394 |
R-HSA-176409 | APC/C:Cdc20 mediated degradation of mitotic proteins | 4.086093e-01 | 0.389 |
R-HSA-176814 | Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | 4.135294e-01 | 0.383 |
R-HSA-193648 | NRAGE signals death through JNK | 4.135294e-01 | 0.383 |
R-HSA-109606 | Intrinsic Pathway for Apoptosis | 4.135294e-01 | 0.383 |
R-HSA-2980766 | Nuclear Envelope Breakdown | 4.184089e-01 | 0.378 |
R-HSA-5621480 | Dectin-2 family | 4.184089e-01 | 0.378 |
R-HSA-191859 | snRNP Assembly | 4.280473e-01 | 0.369 |
R-HSA-194441 | Metabolism of non-coding RNA | 4.280473e-01 | 0.369 |
R-HSA-1660661 | Sphingolipid de novo biosynthesis | 4.328069e-01 | 0.364 |
R-HSA-8943724 | Regulation of PTEN gene transcription | 4.328069e-01 | 0.364 |
R-HSA-212436 | Generic Transcription Pathway | 4.372295e-01 | 0.359 |
R-HSA-168325 | Viral Messenger RNA Synthesis | 4.375271e-01 | 0.359 |
R-HSA-176408 | Regulation of APC/C activators between G1/S and early anaphase | 4.422084e-01 | 0.354 |
R-HSA-6784531 | tRNA processing in the nucleus | 4.422084e-01 | 0.354 |
R-HSA-2559586 | DNA Damage/Telomere Stress Induced Senescence | 4.422084e-01 | 0.354 |
R-HSA-8848021 | Signaling by PTK6 | 4.468510e-01 | 0.350 |
R-HSA-9006927 | Signaling by Non-Receptor Tyrosine Kinases | 4.468510e-01 | 0.350 |
R-HSA-373755 | Semaphorin interactions | 4.468510e-01 | 0.350 |
R-HSA-72203 | Processing of Capped Intron-Containing Pre-mRNA | 4.543075e-01 | 0.343 |
R-HSA-1234174 | Cellular response to hypoxia | 4.560215e-01 | 0.341 |
R-HSA-73857 | RNA Polymerase II Transcription | 4.598392e-01 | 0.337 |
R-HSA-983168 | Antigen processing: Ubiquitination & Proteasome degradation | 4.607770e-01 | 0.337 |
R-HSA-913709 | O-linked glycosylation of mucins | 4.694950e-01 | 0.328 |
R-HSA-167172 | Transcription of the HIV genome | 4.694950e-01 | 0.328 |
R-HSA-453276 | Regulation of mitotic cell cycle | 4.826372e-01 | 0.316 |
R-HSA-174143 | APC/C-mediated degradation of cell cycle proteins | 4.826372e-01 | 0.316 |
R-HSA-3906995 | Diseases associated with O-glycosylation of proteins | 4.826372e-01 | 0.316 |
R-HSA-199992 | trans-Golgi Network Vesicle Budding | 4.869457e-01 | 0.313 |
R-HSA-159236 | Transport of Mature mRNA derived from an Intron-Containing Transcript | 4.912186e-01 | 0.309 |
R-HSA-69052 | Switching of origins to a post-replicative state | 4.912186e-01 | 0.309 |
R-HSA-204998 | Cell death signalling via NRAGE, NRIF and NADE | 4.912186e-01 | 0.309 |
R-HSA-9013694 | Signaling by NOTCH4 | 4.954562e-01 | 0.305 |
R-HSA-5633008 | TP53 Regulates Transcription of Cell Death Genes | 4.996587e-01 | 0.301 |
R-HSA-1169408 | ISG15 antiviral mechanism | 4.996587e-01 | 0.301 |
R-HSA-6796648 | TP53 Regulates Transcription of DNA Repair Genes | 5.120590e-01 | 0.291 |
R-HSA-416482 | G alpha (12/13) signalling events | 5.120590e-01 | 0.291 |
R-HSA-9679506 | SARS-CoV Infections | 5.251278e-01 | 0.280 |
R-HSA-72202 | Transport of Mature Transcript to Cytoplasm | 5.281195e-01 | 0.277 |
R-HSA-72163 | mRNA Splicing - Major Pathway | 5.304694e-01 | 0.275 |
R-HSA-9707564 | Cytoprotection by HMOX1 | 5.320519e-01 | 0.274 |
R-HSA-390918 | Peroxisomal lipid metabolism | 5.359518e-01 | 0.271 |
R-HSA-6794362 | Protein-protein interactions at synapses | 5.398195e-01 | 0.268 |
R-HSA-6804756 | Regulation of TP53 Activity through Phosphorylation | 5.474591e-01 | 0.262 |
R-HSA-376176 | Signaling by ROBO receptors | 5.528181e-01 | 0.257 |
R-HSA-72172 | mRNA Splicing | 5.576827e-01 | 0.254 |
R-HSA-2682334 | EPH-Ephrin signaling | 5.732195e-01 | 0.242 |
R-HSA-983695 | Antigen activates B Cell Receptor (BCR) leading to generation of second messenge... | 5.767788e-01 | 0.239 |
R-HSA-168928 | DDX58/IFIH1-mediated induction of interferon-alpha/beta | 5.838091e-01 | 0.234 |
R-HSA-77289 | Mitochondrial Fatty Acid Beta-Oxidation | 5.838091e-01 | 0.234 |
R-HSA-381340 | Transcriptional regulation of white adipocyte differentiation | 5.907236e-01 | 0.229 |
R-HSA-170834 | Signaling by TGF-beta Receptor Complex | 5.941379e-01 | 0.226 |
R-HSA-193704 | p75 NTR receptor-mediated signalling | 6.008820e-01 | 0.221 |
R-HSA-192105 | Synthesis of bile acids and bile salts | 6.008820e-01 | 0.221 |
R-HSA-1643685 | Disease | 6.024850e-01 | 0.220 |
R-HSA-70171 | Glycolysis | 6.042122e-01 | 0.219 |
R-HSA-3371453 | Regulation of HSF1-mediated heat shock response | 6.107901e-01 | 0.214 |
R-HSA-9006931 | Signaling by Nuclear Receptors | 6.203970e-01 | 0.207 |
R-HSA-9692914 | SARS-CoV-1-host interactions | 6.267639e-01 | 0.203 |
R-HSA-69239 | Synthesis of DNA | 6.298798e-01 | 0.201 |
R-HSA-15869 | Metabolism of nucleotides | 6.304033e-01 | 0.200 |
R-HSA-2672351 | Stimuli-sensing channels | 6.329697e-01 | 0.199 |
R-HSA-202403 | TCR signaling | 6.390731e-01 | 0.194 |
R-HSA-194068 | Bile acid and bile salt metabolism | 6.390731e-01 | 0.194 |
R-HSA-1483249 | Inositol phosphate metabolism | 6.450757e-01 | 0.190 |
R-HSA-168181 | Toll Like Receptor 7/8 (TLR7/8) Cascade | 6.480398e-01 | 0.188 |
R-HSA-983169 | Class I MHC mediated antigen processing & presentation | 6.562351e-01 | 0.183 |
R-HSA-168138 | Toll Like Receptor 9 (TLR9) Cascade | 6.567853e-01 | 0.183 |
R-HSA-2871809 | FCERI mediated Ca+2 mobilization | 6.596523e-01 | 0.181 |
R-HSA-70326 | Glucose metabolism | 6.653151e-01 | 0.177 |
R-HSA-2980736 | Peptide hormone metabolism | 6.653151e-01 | 0.177 |
R-HSA-3371556 | Cellular response to heat stress | 6.763617e-01 | 0.170 |
R-HSA-9711123 | Cellular response to chemical stress | 6.935585e-01 | 0.159 |
R-HSA-8956319 | Nucleotide catabolism | 6.999109e-01 | 0.155 |
R-HSA-9843745 | Adipogenesis | 7.073763e-01 | 0.150 |
R-HSA-5173105 | O-linked glycosylation | 7.240864e-01 | 0.140 |
R-HSA-6807070 | PTEN Regulation | 7.286843e-01 | 0.137 |
R-HSA-9664422 | FCGR3A-mediated phagocytosis | 7.309546e-01 | 0.136 |
R-HSA-9664407 | Parasite infection | 7.309546e-01 | 0.136 |
R-HSA-9664417 | Leishmania phagocytosis | 7.309546e-01 | 0.136 |
R-HSA-2029482 | Regulation of actin dynamics for phagocytic cup formation | 7.332061e-01 | 0.135 |
R-HSA-9705671 | SARS-CoV-2 activates/modulates innate and adaptive immune responses | 7.376531e-01 | 0.132 |
R-HSA-69242 | S Phase | 7.505575e-01 | 0.125 |
R-HSA-9755511 | KEAP1-NFE2L2 pathway | 7.567714e-01 | 0.121 |
R-HSA-9010553 | Regulation of expression of SLITs and ROBOs | 7.588083e-01 | 0.120 |
R-HSA-9609507 | Protein localization | 7.608284e-01 | 0.119 |
R-HSA-73887 | Death Receptor Signaling | 7.628316e-01 | 0.118 |
R-HSA-168273 | Influenza Viral RNA Transcription and Replication | 7.648182e-01 | 0.116 |
R-HSA-1989781 | PPARA activates gene expression | 7.648182e-01 | 0.116 |
R-HSA-400206 | Regulation of lipid metabolism by PPARalpha | 7.687420e-01 | 0.114 |
R-HSA-983705 | Signaling by the B Cell Receptor (BCR) | 7.706794e-01 | 0.113 |
R-HSA-9006936 | Signaling by TGFB family members | 7.745061e-01 | 0.111 |
R-HSA-109581 | Apoptosis | 7.782694e-01 | 0.109 |
R-HSA-5619102 | SLC transporter disorders | 7.874071e-01 | 0.104 |
R-HSA-72306 | tRNA processing | 7.944473e-01 | 0.100 |
R-HSA-5621481 | C-type lectin receptors (CLRs) | 7.961709e-01 | 0.099 |
R-HSA-168249 | Innate Immune System | 7.998497e-01 | 0.097 |
R-HSA-2029480 | Fcgamma receptor (FCGR) dependent phagocytosis | 8.012561e-01 | 0.096 |
R-HSA-9678108 | SARS-CoV-1 Infection | 8.029230e-01 | 0.095 |
R-HSA-611105 | Respiratory electron transport | 8.078410e-01 | 0.093 |
R-HSA-168255 | Influenza Infection | 8.094531e-01 | 0.092 |
R-HSA-3781865 | Diseases of glycosylation | 8.173144e-01 | 0.088 |
R-HSA-983712 | Ion channel transport | 8.248537e-01 | 0.084 |
R-HSA-168898 | Toll-like Receptor Cascades | 8.277822e-01 | 0.082 |
R-HSA-428157 | Sphingolipid metabolism | 8.417114e-01 | 0.075 |
R-HSA-2454202 | Fc epsilon receptor (FCERI) signaling | 8.443601e-01 | 0.073 |
R-HSA-5357801 | Programmed Cell Death | 8.482507e-01 | 0.071 |
R-HSA-9824439 | Bacterial Infection Pathways | 8.588996e-01 | 0.066 |
R-HSA-9748784 | Drug ADME | 8.640247e-01 | 0.063 |
R-HSA-425407 | SLC-mediated transmembrane transport | 8.652799e-01 | 0.063 |
R-HSA-8978868 | Fatty acid metabolism | 8.739400e-01 | 0.059 |
R-HSA-9705683 | SARS-CoV-2-host interactions | 8.750412e-01 | 0.058 |
R-HSA-196849 | Metabolism of water-soluble vitamins and cofactors | 8.771358e-01 | 0.057 |
R-HSA-5668914 | Diseases of metabolism | 8.897523e-01 | 0.051 |
R-HSA-5619115 | Disorders of transmembrane transporters | 8.935892e-01 | 0.049 |
R-HSA-416476 | G alpha (q) signalling events | 9.078534e-01 | 0.042 |
R-HSA-76002 | Platelet activation, signaling and aggregation | 9.153398e-01 | 0.038 |
R-HSA-9658195 | Leishmania infection | 9.202179e-01 | 0.036 |
R-HSA-9824443 | Parasitic Infection Pathways | 9.202179e-01 | 0.036 |
R-HSA-5673001 | RAF/MAP kinase cascade | 9.254521e-01 | 0.034 |
R-HSA-1257604 | PIP3 activates AKT signaling | 9.291527e-01 | 0.032 |
R-HSA-5684996 | MAPK1/MAPK3 signaling | 9.297515e-01 | 0.032 |
R-HSA-8957322 | Metabolism of steroids | 9.446230e-01 | 0.025 |
R-HSA-1474244 | Extracellular matrix organization | 9.478236e-01 | 0.023 |
R-HSA-1428517 | Aerobic respiration and respiratory electron transport | 9.520799e-01 | 0.021 |
R-HSA-9006925 | Intracellular signaling by second messengers | 9.524861e-01 | 0.021 |
R-HSA-5683057 | MAPK family signaling cascades | 9.544664e-01 | 0.020 |
R-HSA-9694516 | SARS-CoV-2 Infection | 9.552353e-01 | 0.020 |
R-HSA-196854 | Metabolism of vitamins and cofactors | 9.606062e-01 | 0.017 |
R-HSA-9006934 | Signaling by Receptor Tyrosine Kinases | 9.701593e-01 | 0.013 |
R-HSA-449147 | Signaling by Interleukins | 9.726579e-01 | 0.012 |
R-HSA-8953854 | Metabolism of RNA | 9.757451e-01 | 0.011 |
R-HSA-71387 | Metabolism of carbohydrates and carbohydrate derivatives | 9.820600e-01 | 0.008 |
R-HSA-388396 | GPCR downstream signalling | 9.909962e-01 | 0.004 |
R-HSA-382551 | Transport of small molecules | 9.910350e-01 | 0.004 |
R-HSA-372790 | Signaling by GPCR | 9.952350e-01 | 0.002 |
R-HSA-71291 | Metabolism of amino acids and derivatives | 9.955983e-01 | 0.002 |
R-HSA-556833 | Metabolism of lipids | 9.962214e-01 | 0.002 |
R-HSA-1430728 | Metabolism | 9.999997e-01 | 0.000 |
Download
kinase | JSD_mean | pearson_surrounding | kinase_max_IC_position | max_position_JSD |
---|---|---|---|---|
COT |
0.768 | 0.181 | 2 | 0.812 |
MOS |
0.760 | 0.271 | 1 | 0.715 |
MST4 |
0.760 | 0.138 | 2 | 0.819 |
GRK1 |
0.755 | 0.255 | -2 | 0.771 |
CLK3 |
0.750 | 0.052 | 1 | 0.677 |
NLK |
0.749 | 0.041 | 1 | 0.717 |
PKN2 |
0.749 | 0.094 | -3 | 0.778 |
PKN3 |
0.749 | 0.082 | -3 | 0.775 |
WNK1 |
0.747 | 0.051 | -2 | 0.759 |
RAF1 |
0.747 | 0.040 | 1 | 0.767 |
PRPK |
0.747 | -0.002 | -1 | 0.308 |
MTOR |
0.747 | -0.019 | 1 | 0.725 |
IKKB |
0.746 | 0.024 | -2 | 0.635 |
KIS |
0.744 | 0.092 | 1 | 0.587 |
PIM3 |
0.744 | -0.011 | -3 | 0.800 |
TBK1 |
0.744 | 0.033 | 1 | 0.731 |
DSTYK |
0.743 | 0.025 | 2 | 0.839 |
MLK1 |
0.743 | 0.059 | 2 | 0.782 |
PKCD |
0.743 | 0.043 | 2 | 0.774 |
RIPK3 |
0.743 | 0.047 | 3 | 0.668 |
IKKE |
0.743 | 0.047 | 1 | 0.729 |
CAMK2G |
0.742 | 0.040 | 2 | 0.722 |
CDC7 |
0.742 | -0.062 | 1 | 0.692 |
CAMK1B |
0.740 | -0.010 | -3 | 0.803 |
GCN2 |
0.740 | -0.053 | 2 | 0.714 |
CHAK2 |
0.739 | -0.014 | -1 | 0.312 |
NIK |
0.739 | 0.003 | -3 | 0.824 |
MLK3 |
0.738 | 0.062 | 2 | 0.740 |
ULK2 |
0.738 | -0.078 | 2 | 0.721 |
SRPK1 |
0.737 | 0.027 | -3 | 0.697 |
BMPR2 |
0.737 | -0.084 | -2 | 0.701 |
PDHK4 |
0.737 | -0.138 | 1 | 0.760 |
CDKL1 |
0.737 | -0.004 | -3 | 0.741 |
NUAK2 |
0.736 | -0.022 | -3 | 0.794 |
NEK6 |
0.736 | -0.048 | -2 | 0.674 |
BCKDK |
0.736 | -0.036 | -1 | 0.269 |
PIM1 |
0.736 | 0.001 | -3 | 0.742 |
PRKD2 |
0.735 | -0.014 | -3 | 0.743 |
ERK5 |
0.735 | -0.047 | 1 | 0.656 |
PKCB |
0.735 | 0.040 | 2 | 0.739 |
TGFBR2 |
0.735 | -0.032 | -2 | 0.604 |
NDR1 |
0.734 | -0.021 | -3 | 0.798 |
AMPKA1 |
0.734 | -0.018 | -3 | 0.810 |
AURC |
0.734 | 0.004 | -2 | 0.539 |
PKCA |
0.734 | 0.044 | 2 | 0.730 |
PKACG |
0.734 | -0.006 | -2 | 0.633 |
NDR2 |
0.734 | -0.047 | -3 | 0.816 |
PKCG |
0.734 | 0.048 | 2 | 0.721 |
PDHK1 |
0.733 | -0.106 | 1 | 0.758 |
IRE1 |
0.733 | -0.013 | 1 | 0.667 |
NEK7 |
0.733 | -0.070 | -3 | 0.771 |
SKMLCK |
0.733 | -0.033 | -2 | 0.733 |
MNK2 |
0.732 | -0.012 | -2 | 0.639 |
MLK2 |
0.732 | -0.027 | 2 | 0.790 |
RIPK1 |
0.732 | -0.039 | 1 | 0.724 |
FAM20C |
0.732 | 0.088 | 2 | 0.674 |
GRK5 |
0.731 | -0.089 | -3 | 0.784 |
IKKA |
0.731 | -0.014 | -2 | 0.617 |
MAPKAPK3 |
0.731 | -0.025 | -3 | 0.739 |
GRK6 |
0.731 | -0.004 | 1 | 0.697 |
CDKL5 |
0.731 | -0.020 | -3 | 0.737 |
WNK3 |
0.731 | -0.082 | 1 | 0.720 |
PKR |
0.731 | 0.022 | 1 | 0.714 |
MST3 |
0.731 | 0.132 | 2 | 0.789 |
CAMLCK |
0.730 | -0.037 | -2 | 0.694 |
PKCH |
0.730 | 0.033 | 2 | 0.708 |
ATR |
0.730 | -0.074 | 1 | 0.670 |
GRK7 |
0.730 | 0.080 | 1 | 0.646 |
ANKRD3 |
0.730 | 0.016 | 1 | 0.749 |
RSK2 |
0.730 | -0.027 | -3 | 0.731 |
HUNK |
0.729 | -0.061 | 2 | 0.701 |
PHKG1 |
0.729 | 0.027 | -3 | 0.781 |
PKCZ |
0.728 | -0.012 | 2 | 0.744 |
DLK |
0.728 | -0.021 | 1 | 0.696 |
CDK1 |
0.728 | 0.034 | 1 | 0.535 |
CAMK2D |
0.728 | -0.051 | -3 | 0.780 |
NEK9 |
0.727 | -0.103 | 2 | 0.781 |
BMPR1B |
0.727 | 0.037 | 1 | 0.637 |
P70S6KB |
0.727 | -0.022 | -3 | 0.748 |
PRKD1 |
0.727 | -0.068 | -3 | 0.784 |
YSK4 |
0.727 | 0.029 | 1 | 0.706 |
MNK1 |
0.727 | -0.005 | -2 | 0.644 |
AMPKA2 |
0.727 | -0.031 | -3 | 0.784 |
TSSK2 |
0.727 | -0.044 | -5 | 0.784 |
MLK4 |
0.726 | 0.011 | 2 | 0.704 |
CDK5 |
0.726 | 0.021 | 1 | 0.575 |
CAMK4 |
0.726 | -0.030 | -3 | 0.770 |
ICK |
0.726 | -0.047 | -3 | 0.782 |
CAMK2B |
0.725 | 0.002 | 2 | 0.718 |
PKG2 |
0.725 | 0.001 | -2 | 0.563 |
GRK4 |
0.725 | -0.021 | -2 | 0.738 |
TTBK2 |
0.725 | -0.025 | 2 | 0.614 |
RSK3 |
0.725 | -0.044 | -3 | 0.720 |
SRPK2 |
0.725 | 0.013 | -3 | 0.624 |
DAPK2 |
0.725 | -0.075 | -3 | 0.806 |
MARK4 |
0.725 | -0.081 | 4 | 0.780 |
CHAK1 |
0.725 | -0.032 | 2 | 0.716 |
ULK1 |
0.725 | -0.107 | -3 | 0.761 |
AURB |
0.725 | -0.008 | -2 | 0.535 |
P90RSK |
0.725 | -0.054 | -3 | 0.734 |
CDK7 |
0.724 | -0.026 | 1 | 0.569 |
MELK |
0.723 | -0.039 | -3 | 0.764 |
MAPKAPK2 |
0.723 | -0.018 | -3 | 0.707 |
PRKD3 |
0.723 | -0.019 | -3 | 0.691 |
TGFBR1 |
0.723 | 0.009 | -2 | 0.635 |
TSSK1 |
0.722 | -0.057 | -3 | 0.835 |
HIPK4 |
0.722 | -0.059 | 1 | 0.671 |
TAO3 |
0.722 | 0.057 | 1 | 0.705 |
MEKK3 |
0.722 | 0.083 | 1 | 0.702 |
PAK6 |
0.722 | -0.012 | -2 | 0.570 |
LATS1 |
0.722 | 0.001 | -3 | 0.837 |
PAK1 |
0.721 | -0.045 | -2 | 0.650 |
CAMK2A |
0.721 | -0.019 | 2 | 0.714 |
MASTL |
0.721 | -0.127 | -2 | 0.683 |
NEK2 |
0.721 | -0.066 | 2 | 0.757 |
PLK1 |
0.721 | -0.024 | -2 | 0.598 |
SRPK3 |
0.721 | 0.012 | -3 | 0.659 |
CDK18 |
0.721 | -0.002 | 1 | 0.512 |
IRE2 |
0.720 | -0.043 | 2 | 0.711 |
SGK3 |
0.720 | -0.001 | -3 | 0.707 |
DNAPK |
0.720 | -0.014 | 1 | 0.670 |
PRKX |
0.720 | 0.018 | -3 | 0.659 |
CLK4 |
0.720 | -0.011 | -3 | 0.719 |
AKT2 |
0.720 | 0.010 | -3 | 0.640 |
DRAK1 |
0.720 | -0.010 | 1 | 0.691 |
PKCE |
0.720 | 0.059 | 2 | 0.714 |
NIM1 |
0.720 | -0.104 | 3 | 0.714 |
MYLK4 |
0.720 | -0.011 | -2 | 0.657 |
QIK |
0.720 | -0.069 | -3 | 0.767 |
CLK1 |
0.719 | 0.000 | -3 | 0.698 |
CDK2 |
0.719 | 0.012 | 1 | 0.595 |
ZAK |
0.719 | 0.001 | 1 | 0.672 |
ALK4 |
0.719 | -0.035 | -2 | 0.653 |
RSK4 |
0.719 | -0.010 | -3 | 0.716 |
CDK3 |
0.719 | 0.044 | 1 | 0.483 |
PKCT |
0.719 | 0.007 | 2 | 0.722 |
IRAK4 |
0.719 | -0.036 | 1 | 0.688 |
ALK2 |
0.718 | 0.008 | -2 | 0.665 |
PKACB |
0.718 | -0.008 | -2 | 0.560 |
ATM |
0.718 | -0.058 | 1 | 0.626 |
CDK8 |
0.718 | -0.049 | 1 | 0.549 |
CK1E |
0.718 | 0.075 | -3 | 0.475 |
PKCI |
0.718 | 0.009 | 2 | 0.718 |
CDK10 |
0.718 | 0.038 | 1 | 0.550 |
LATS2 |
0.718 | -0.080 | -5 | 0.647 |
CDK13 |
0.717 | -0.031 | 1 | 0.559 |
PAK3 |
0.717 | -0.079 | -2 | 0.649 |
NUAK1 |
0.717 | -0.064 | -3 | 0.754 |
MEK1 |
0.717 | -0.083 | 2 | 0.756 |
CDK16 |
0.717 | 0.031 | 1 | 0.484 |
HIPK1 |
0.717 | -0.004 | 1 | 0.613 |
HIPK2 |
0.717 | -0.001 | 1 | 0.533 |
PHKG2 |
0.717 | 0.030 | -3 | 0.748 |
HPK1 |
0.716 | 0.129 | 1 | 0.763 |
CAMK1G |
0.716 | 0.003 | -3 | 0.703 |
MPSK1 |
0.716 | 0.005 | 1 | 0.642 |
WNK4 |
0.716 | -0.045 | -2 | 0.748 |
JNK2 |
0.716 | -0.002 | 1 | 0.547 |
GCK |
0.715 | 0.119 | 1 | 0.745 |
ACVR2B |
0.715 | 0.020 | -2 | 0.606 |
PIM2 |
0.715 | -0.016 | -3 | 0.698 |
AURA |
0.715 | -0.011 | -2 | 0.503 |
VRK2 |
0.715 | -0.143 | 1 | 0.724 |
HRI |
0.714 | -0.078 | -2 | 0.648 |
CLK2 |
0.714 | 0.018 | -3 | 0.716 |
ACVR2A |
0.714 | -0.021 | -2 | 0.579 |
AKT1 |
0.714 | 0.006 | -3 | 0.663 |
MINK |
0.714 | 0.110 | 1 | 0.742 |
CDK17 |
0.714 | -0.005 | 1 | 0.471 |
MEKK2 |
0.714 | -0.010 | 2 | 0.759 |
TAO2 |
0.714 | 0.038 | 2 | 0.808 |
KHS2 |
0.713 | 0.129 | 1 | 0.769 |
ERK2 |
0.713 | -0.027 | 1 | 0.583 |
ERK1 |
0.713 | -0.020 | 1 | 0.544 |
P38A |
0.713 | -0.035 | 1 | 0.597 |
CDK19 |
0.713 | -0.046 | 1 | 0.521 |
PERK |
0.713 | -0.077 | -2 | 0.663 |
MEK5 |
0.713 | -0.051 | 2 | 0.758 |
NEK11 |
0.713 | 0.063 | 1 | 0.741 |
CDK14 |
0.712 | 0.001 | 1 | 0.561 |
BRAF |
0.712 | -0.065 | -4 | 0.712 |
TNIK |
0.712 | 0.085 | 3 | 0.826 |
JNK3 |
0.712 | -0.015 | 1 | 0.570 |
KHS1 |
0.712 | 0.114 | 1 | 0.760 |
CDK12 |
0.712 | -0.030 | 1 | 0.543 |
PLK3 |
0.712 | -0.045 | 2 | 0.651 |
GAK |
0.712 | 0.067 | 1 | 0.683 |
GRK2 |
0.711 | -0.010 | -2 | 0.631 |
MSK2 |
0.711 | -0.064 | -3 | 0.681 |
PLK4 |
0.711 | -0.035 | 2 | 0.503 |
PAK2 |
0.711 | -0.079 | -2 | 0.637 |
DYRK2 |
0.711 | -0.047 | 1 | 0.600 |
DCAMKL1 |
0.711 | -0.036 | -3 | 0.756 |
MEKK1 |
0.711 | -0.069 | 1 | 0.690 |
P38G |
0.710 | -0.009 | 1 | 0.467 |
QSK |
0.710 | -0.083 | 4 | 0.756 |
BMPR1A |
0.710 | 0.004 | 1 | 0.619 |
CDK9 |
0.710 | -0.047 | 1 | 0.573 |
HASPIN |
0.710 | 0.030 | -1 | 0.277 |
SIK |
0.709 | -0.070 | -3 | 0.717 |
NEK5 |
0.709 | -0.084 | 1 | 0.709 |
CK1D |
0.709 | 0.065 | -3 | 0.422 |
TAK1 |
0.709 | 0.103 | 1 | 0.731 |
SSTK |
0.709 | -0.022 | 4 | 0.750 |
HGK |
0.708 | 0.037 | 3 | 0.818 |
P38B |
0.708 | -0.029 | 1 | 0.537 |
CHK1 |
0.708 | -0.096 | -3 | 0.816 |
MSK1 |
0.708 | -0.045 | -3 | 0.694 |
TLK2 |
0.708 | -0.114 | 1 | 0.662 |
SMG1 |
0.708 | -0.117 | 1 | 0.630 |
PDK1 |
0.708 | 0.011 | 1 | 0.783 |
PKN1 |
0.707 | 0.017 | -3 | 0.664 |
MARK3 |
0.707 | -0.065 | 4 | 0.727 |
SNRK |
0.707 | -0.081 | 2 | 0.568 |
PASK |
0.706 | -0.007 | -3 | 0.802 |
IRAK1 |
0.706 | -0.103 | -1 | 0.279 |
MST2 |
0.706 | 0.053 | 1 | 0.723 |
HIPK3 |
0.706 | -0.037 | 1 | 0.632 |
NEK8 |
0.706 | -0.043 | 2 | 0.758 |
PKACA |
0.706 | -0.017 | -2 | 0.511 |
BRSK1 |
0.706 | -0.066 | -3 | 0.745 |
BRSK2 |
0.706 | -0.077 | -3 | 0.763 |
CK2A2 |
0.705 | 0.059 | 1 | 0.557 |
DCAMKL2 |
0.705 | -0.026 | -3 | 0.775 |
MAPKAPK5 |
0.705 | -0.091 | -3 | 0.647 |
LOK |
0.705 | -0.001 | -2 | 0.622 |
PRP4 |
0.705 | -0.024 | -3 | 0.708 |
EEF2K |
0.704 | 0.022 | 3 | 0.822 |
GSK3A |
0.703 | 0.012 | 4 | 0.475 |
NEK4 |
0.703 | -0.038 | 1 | 0.722 |
ERK7 |
0.703 | -0.014 | 2 | 0.526 |
SMMLCK |
0.703 | -0.046 | -3 | 0.750 |
CK1A2 |
0.703 | 0.053 | -3 | 0.419 |
TLK1 |
0.702 | -0.074 | -2 | 0.673 |
GRK3 |
0.702 | 0.007 | -2 | 0.619 |
GSK3B |
0.702 | 0.002 | 4 | 0.468 |
MAP3K15 |
0.702 | -0.002 | 1 | 0.681 |
MARK2 |
0.702 | -0.088 | 4 | 0.679 |
BUB1 |
0.702 | 0.010 | -5 | 0.741 |
PAK5 |
0.701 | -0.046 | -2 | 0.515 |
MST1 |
0.701 | 0.052 | 1 | 0.721 |
AKT3 |
0.701 | 0.003 | -3 | 0.583 |
CAMKK1 |
0.701 | -0.118 | -2 | 0.653 |
SLK |
0.701 | -0.011 | -2 | 0.572 |
CDK6 |
0.701 | -0.003 | 1 | 0.546 |
P70S6K |
0.701 | -0.048 | -3 | 0.649 |
TTBK1 |
0.700 | -0.067 | 2 | 0.530 |
PINK1 |
0.700 | -0.169 | 1 | 0.681 |
BMPR2_TYR |
0.700 | 0.298 | -1 | 0.437 |
ROCK2 |
0.700 | 0.008 | -3 | 0.745 |
MARK1 |
0.699 | -0.090 | 4 | 0.742 |
YSK1 |
0.699 | 0.003 | 2 | 0.773 |
MEKK6 |
0.699 | -0.042 | 1 | 0.656 |
LRRK2 |
0.699 | -0.062 | 2 | 0.763 |
CAMK1D |
0.699 | -0.034 | -3 | 0.643 |
DYRK1A |
0.698 | -0.053 | 1 | 0.637 |
MRCKB |
0.698 | 0.001 | -3 | 0.687 |
CK1G1 |
0.697 | -0.014 | -3 | 0.476 |
NEK1 |
0.697 | -0.061 | 1 | 0.705 |
PDHK3_TYR |
0.697 | 0.051 | 4 | 0.847 |
LKB1 |
0.697 | -0.109 | -3 | 0.765 |
CK2A1 |
0.697 | 0.058 | 1 | 0.541 |
CDK4 |
0.696 | -0.020 | 1 | 0.528 |
PAK4 |
0.695 | -0.047 | -2 | 0.509 |
SGK1 |
0.695 | -0.007 | -3 | 0.566 |
DAPK3 |
0.695 | -0.037 | -3 | 0.754 |
VRK1 |
0.695 | -0.055 | 2 | 0.764 |
TESK1_TYR |
0.695 | 0.049 | 3 | 0.818 |
DYRK3 |
0.695 | -0.048 | 1 | 0.619 |
DYRK1B |
0.694 | -0.045 | 1 | 0.563 |
PLK2 |
0.693 | 0.003 | -3 | 0.765 |
CAMKK2 |
0.693 | -0.143 | -2 | 0.634 |
CHK2 |
0.693 | -0.022 | -3 | 0.588 |
MAK |
0.693 | -0.018 | -2 | 0.569 |
PDHK4_TYR |
0.693 | 0.090 | 2 | 0.785 |
MRCKA |
0.692 | -0.017 | -3 | 0.708 |
P38D |
0.692 | -0.036 | 1 | 0.481 |
DYRK4 |
0.692 | -0.040 | 1 | 0.537 |
MOK |
0.692 | -0.027 | 1 | 0.614 |
CAMK1A |
0.691 | -0.023 | -3 | 0.611 |
OSR1 |
0.690 | 0.028 | 2 | 0.751 |
STK33 |
0.690 | -0.088 | 2 | 0.519 |
MYO3A |
0.690 | 0.054 | 1 | 0.720 |
JNK1 |
0.690 | -0.026 | 1 | 0.527 |
DAPK1 |
0.690 | -0.030 | -3 | 0.724 |
DMPK1 |
0.690 | 0.012 | -3 | 0.713 |
RIPK2 |
0.689 | -0.090 | 1 | 0.680 |
LIMK2_TYR |
0.688 | -0.031 | -3 | 0.841 |
PINK1_TYR |
0.687 | 0.015 | 1 | 0.709 |
EPHA6 |
0.687 | 0.163 | -1 | 0.421 |
TAO1 |
0.687 | -0.001 | 1 | 0.675 |
ROCK1 |
0.687 | -0.005 | -3 | 0.705 |
PKMYT1_TYR |
0.687 | -0.045 | 3 | 0.790 |
MYO3B |
0.687 | -0.003 | 2 | 0.783 |
LCK |
0.687 | 0.199 | -1 | 0.424 |
PDHK1_TYR |
0.687 | 0.082 | -1 | 0.370 |
ALPHAK3 |
0.686 | 0.039 | -1 | 0.315 |
MAP2K7_TYR |
0.686 | -0.058 | 2 | 0.769 |
MAP2K6_TYR |
0.686 | 0.009 | -1 | 0.340 |
MAP2K4_TYR |
0.684 | -0.101 | -1 | 0.313 |
MEK2 |
0.682 | -0.160 | 2 | 0.730 |
PBK |
0.682 | -0.074 | 1 | 0.611 |
TTK |
0.682 | -0.028 | -2 | 0.630 |
PKG1 |
0.681 | -0.050 | -2 | 0.492 |
NEK3 |
0.681 | -0.124 | 1 | 0.676 |
FYN |
0.681 | 0.215 | -1 | 0.459 |
HCK |
0.681 | 0.125 | -1 | 0.393 |
LIMK1_TYR |
0.680 | -0.102 | 2 | 0.788 |
BLK |
0.680 | 0.150 | -1 | 0.421 |
RET |
0.680 | -0.044 | 1 | 0.697 |
JAK3 |
0.679 | 0.097 | 1 | 0.676 |
TYK2 |
0.679 | -0.034 | 1 | 0.699 |
ASK1 |
0.679 | -0.041 | 1 | 0.673 |
MST1R |
0.678 | -0.011 | 3 | 0.724 |
ABL2 |
0.678 | -0.024 | -1 | 0.295 |
CSF1R |
0.677 | -0.018 | 3 | 0.718 |
TXK |
0.677 | 0.061 | 1 | 0.636 |
YES1 |
0.677 | -0.015 | -1 | 0.323 |
CRIK |
0.676 | -0.027 | -3 | 0.664 |
NEK10_TYR |
0.676 | -0.020 | 1 | 0.660 |
SBK |
0.676 | -0.044 | -3 | 0.534 |
WEE1_TYR |
0.676 | -0.011 | -1 | 0.265 |
BIKE |
0.676 | -0.038 | 1 | 0.580 |
ROS1 |
0.675 | -0.050 | 3 | 0.704 |
EPHB4 |
0.675 | -0.002 | -1 | 0.345 |
JAK2 |
0.675 | -0.028 | 1 | 0.696 |
TYRO3 |
0.675 | -0.106 | 3 | 0.733 |
PTK2 |
0.674 | 0.237 | -1 | 0.544 |
INSRR |
0.673 | 0.029 | 3 | 0.673 |
SYK |
0.673 | 0.240 | -1 | 0.480 |
ITK |
0.673 | 0.018 | -1 | 0.347 |
ABL1 |
0.673 | -0.058 | -1 | 0.282 |
JAK1 |
0.672 | 0.002 | 1 | 0.689 |
KDR |
0.672 | 0.029 | 3 | 0.677 |
FGR |
0.671 | -0.034 | 1 | 0.665 |
BMX |
0.671 | 0.010 | -1 | 0.323 |
MET |
0.670 | 0.057 | 3 | 0.686 |
KIT |
0.670 | -0.018 | 3 | 0.718 |
FLT1 |
0.668 | 0.083 | -1 | 0.404 |
EPHA4 |
0.668 | 0.019 | 2 | 0.654 |
TNK1 |
0.667 | -0.115 | 3 | 0.720 |
CK1A |
0.667 | 0.016 | -3 | 0.338 |
TEC |
0.667 | -0.065 | -1 | 0.267 |
FLT3 |
0.667 | -0.045 | 3 | 0.734 |
DDR1 |
0.666 | -0.143 | 4 | 0.773 |
SRMS |
0.665 | -0.057 | 1 | 0.669 |
LYN |
0.665 | 0.063 | 3 | 0.666 |
FER |
0.665 | -0.100 | 1 | 0.679 |
TNNI3K_TYR |
0.665 | -0.101 | 1 | 0.655 |
PDGFRB |
0.664 | -0.121 | 3 | 0.728 |
BTK |
0.664 | -0.088 | -1 | 0.282 |
STLK3 |
0.664 | -0.067 | 1 | 0.650 |
EPHB2 |
0.664 | -0.005 | -1 | 0.351 |
FGFR2 |
0.664 | -0.063 | 3 | 0.704 |
YANK3 |
0.664 | -0.046 | 2 | 0.313 |
ERBB2 |
0.664 | 0.024 | 1 | 0.646 |
EPHB1 |
0.664 | -0.040 | 1 | 0.666 |
FRK |
0.664 | 0.048 | -1 | 0.375 |
TNK2 |
0.662 | -0.125 | 3 | 0.652 |
SRC |
0.662 | 0.058 | -1 | 0.384 |
EPHB3 |
0.661 | -0.041 | -1 | 0.340 |
AAK1 |
0.661 | -0.030 | 1 | 0.493 |
MERTK |
0.659 | -0.119 | 3 | 0.685 |
PDGFRA |
0.659 | -0.126 | 3 | 0.738 |
EPHA7 |
0.658 | 0.000 | 2 | 0.660 |
ALK |
0.658 | -0.106 | 3 | 0.650 |
FGFR1 |
0.658 | -0.112 | 3 | 0.677 |
AXL |
0.657 | -0.162 | 3 | 0.673 |
FGFR3 |
0.657 | -0.032 | 3 | 0.675 |
TEK |
0.657 | -0.084 | 3 | 0.669 |
EPHA3 |
0.656 | -0.030 | 2 | 0.627 |
ZAP70 |
0.656 | 0.112 | -1 | 0.422 |
EPHA1 |
0.656 | -0.049 | 3 | 0.660 |
PTK6 |
0.656 | -0.171 | -1 | 0.240 |
FLT4 |
0.655 | -0.054 | 3 | 0.687 |
LTK |
0.655 | -0.127 | 3 | 0.670 |
EPHA8 |
0.654 | 0.057 | -1 | 0.411 |
EGFR |
0.654 | -0.002 | 1 | 0.549 |
INSR |
0.653 | -0.075 | 3 | 0.650 |
MATK |
0.651 | -0.099 | -1 | 0.262 |
NTRK2 |
0.651 | -0.140 | 3 | 0.678 |
NTRK1 |
0.651 | -0.142 | -1 | 0.289 |
CK1G3 |
0.650 | -0.008 | -3 | 0.292 |
DDR2 |
0.650 | -0.094 | 3 | 0.644 |
ERBB4 |
0.650 | 0.083 | 1 | 0.550 |
EPHA5 |
0.650 | -0.024 | 2 | 0.643 |
PTK2B |
0.647 | -0.114 | -1 | 0.269 |
FGFR4 |
0.647 | -0.063 | -1 | 0.295 |
NTRK3 |
0.647 | -0.123 | -1 | 0.262 |
MUSK |
0.647 | -0.063 | 1 | 0.543 |
EPHA2 |
0.646 | 0.041 | -1 | 0.405 |
CK1G2 |
0.646 | 0.078 | -3 | 0.388 |
CSK |
0.645 | -0.108 | 2 | 0.661 |
IGF1R |
0.642 | -0.037 | 3 | 0.599 |
YANK2 |
0.640 | -0.048 | 2 | 0.347 |
FES |
0.629 | -0.095 | -1 | 0.285 |